def14a
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant x
Filed by a Party other than the Registrant o
Check the appropriate box:
|
|
|
|
|
|
|
o
|
|
Preliminary Proxy Statement
|
|
o
|
|
Confidential, for
Use of the Commission Only (as
permitted by Rule 14a-6(e)(2)) |
x
|
|
Definitive Proxy Statement |
|
|
|
|
o
|
|
Definitive Additional Materials |
|
|
|
|
o
|
|
Soliciting Material Pursuant to Section 240.14a-12 |
|
|
|
|
Cerner Corporation
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
x |
|
No fee required. |
|
o |
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
(1) |
|
Title of each class of securities to which transaction applies: |
|
|
|
|
|
|
|
(2) |
|
Aggregate number of securities to which transaction applies: |
|
|
|
|
|
|
|
(3) |
|
Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which
the filing fee is calculated and state how it was determined): |
April 17, 2006
Dear Shareholder:
You are cordially invited to attend the Annual Meeting of Shareholders of Cerner Corporation (the
Company) to be held at 10:00 a.m., local time, on May 26, 2006, at The Cerner Round auditorium in
the Cerner Vision Center, located on the Cerner campus at 2850 Rockcreek Parkway, North Kansas
City, Missouri 64117.
Details of the business to be conducted at the Annual Meeting of Shareholders are given in the
attached Notice of Annual Meeting and Proxy Statement. We will also report on matters of current
interest to our shareholders. We hope you will be able to attend the meeting. However, even if
you plan to attend in person, please vote your shares promptly to ensure they are represented at
the meeting. You may submit your proxy vote by telephone or Internet as described in the following
materials or by completing and signing the enclosed Proxy Card and returning it in the envelope
provided. If you decide to attend the meeting and wish to change your proxy vote, you may do so
automatically by voting in person at the meeting.
The prompt return of your Proxy in the enclosed postage prepaid envelope will help ensure that as
many shares as possible are represented.
Very truly yours,
CERNER CORPORATION
Neal L. Patterson
Chairman of the Board of Directors and
Chief Executive Officer
CERNER CORPORATION
2800 Rockcreek Parkway
North Kansas City, Missouri 64117
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
MAY 26, 2006
TO OUR SHAREHOLDERS:
The Annual Meeting of Shareholders of Cerner Corporation will be held on May 26, 2006, at
10:00 a.m. local time, at our corporate headquarters, 2850 Rockcreek Parkway, North Kansas City,
Missouri 64117, at The Cerner Round auditorium in the Cerner Vision Center, for the following
purposes:
|
1. |
|
The election of two directors, each to serve for a three year term; |
|
|
2. |
|
The ratification of the appointment of KPMG LLP as the independent registered
public accounting firm of Cerner Corporation for 2006; |
|
|
3. |
|
The re-approval of the Cerner Corporation Performance-based Compensation Plan;
and |
|
|
4. |
|
Any other business that may properly come before the Annual Meeting of
Shareholders or any adjournment thereof. |
These items are more fully described in the following pages, which are made part of this
notice.
The holder of record of each share of our common stock at the close of business on March 31,
2006 is entitled to receive notice of and to vote at the Annual Meeting of Shareholders or any
adjournment or postponement of the meeting. Shares of common stock can be voted at the Annual
Meeting of Shareholders only if the holder is present in person or by valid proxy. The Board of
Directors of Cerner Corporation solicits you to sign, date and promptly mail the Proxy Card in the
enclosed postage prepaid envelope or to vote your shares by telephone or the Internet, regardless
of whether or not you intend to be present at the Annual Meeting of Shareholders. You are urged,
however, to attend the Annual Meeting of Shareholders.
A copy of our Annual Report to Shareholders, which includes audited consolidated financial
statements, is enclosed. The Annual Report is not part of our proxy soliciting material.
BY ORDER OF THE BOARD OF DIRECTORS,
Randy D. Sims
Secretary
You may vote your shares by telephone, via the Internet or by mail by following the instructions on
your Proxy Card. If you vote by telephone or via the Internet, you should not return your Proxy
Card. If you choose to vote by mail, please sign, date and return the Proxy Card in the envelope
provided. The Proxy may be revoked at any time before your shares are voted at the meeting by
submitting written notice of revocation to the Secretary of Cerner Corporation or by submitting
another timely proxy by telephone, Internet or mail. If you are present at the meeting, you may
choose to vote your shares in person, and the Proxy will not be used. If you hold shares through a
broker or other custodian, please check the voting instructions used by that broker or custodian.
PROXY STATEMENT
TABLE OF CONTENTS
|
|
|
|
|
|
|
Page |
|
|
|
|
1 |
|
|
|
|
4 |
|
|
|
|
6 |
|
|
|
|
6 |
|
|
|
|
7 |
|
|
|
|
7 |
|
|
|
|
8 |
|
|
|
|
9 |
|
|
|
|
10 |
|
|
|
|
13 |
|
|
|
|
13 |
|
|
|
|
14 |
|
|
|
|
14 |
|
|
|
|
15 |
|
|
|
|
15 |
|
|
|
|
16 |
|
|
|
|
16 |
|
|
|
|
17 |
|
|
|
|
18 |
|
|
|
|
19 |
|
|
|
|
20 |
|
|
|
|
21 |
|
|
|
|
22 |
|
|
|
|
23 |
|
|
|
|
23 |
|
|
|
|
23 |
|
|
|
|
24 |
|
|
|
|
24 |
|
|
|
|
25 |
|
|
|
|
25 |
|
|
|
|
25 |
|
|
|
|
25 |
|
|
|
|
26 |
|
|
|
|
26 |
|
|
|
|
27 |
|
|
|
|
27 |
|
|
|
|
28 |
|
|
|
|
28 |
|
|
|
|
|
|
|
|
Annex-1 |
CERNER CORPORATION
2800 Rockcreek Parkway
North Kansas City, Missouri 64117
2006 ANNUAL MEETING OF SHAREHOLDERS
MAY 26, 2006
This Proxy Statement, which is being mailed on or about April 17, 2006, is furnished to you in
connection with the solicitation of proxies by the Board of Directors (the Board) of Cerner
Corporation, a Delaware corporation (the Company), for use at the Annual Meeting of Shareholders
of the Company to be held on May 26, 2006, commencing at 10:00 a.m., local time, at The Cerner
Round auditorium in the Cerner Vision Center, located on the Cerner campus at 2850 Rockcreek
Parkway, North Kansas City, Missouri 64117, and any adjournment thereof (the Annual Meeting).
Your vote is very important. For this reason, the Board is requesting that you allow your Common
Stock to be represented at the Annual Meeting of Shareholders by the persons named as proxies on
the enclosed proxy card.
GENERAL INFORMATION
|
|
|
Who can vote?
|
|
You are entitled to vote your outstanding shares of common
stock, par value $.01 per share, of the Company (Common
Stock) if our records showed that you held your shares as
of March 31, 2006, the record date for our meeting. At the
close of business on that date, 77,407,122 shares of Common
Stock were outstanding and entitled to vote. Each share of
Common Stock has one vote. The enclosed Proxy Card shows
the number of shares that you are entitled to vote. Your
individual vote is confidential and will not be disclosed to
third parties. |
|
|
|
How do I vote?
|
|
If your Common Stock is held by a broker, bank or other
nominee (i.e., in street name), you will receive
instructions from it that you must follow in order to have
your shares voted.
If you hold your shares in your own name (i.e., as a holder
of record), you may vote your shares by mail, by telephone
or over the Internet. To vote by mail, you may instruct the
persons named as proxies how to vote your Common Stock by
signing, dating and mailing the Proxy Card in the envelope
provided. You may vote by telephone or Internet 24 hours a
day, 7 days a week until 11:59 p.m. (CT) on May 25, 2006.
The enclosed Proxy Card contains instructions for telephone
and Internet voting. Of course, you can always come to the
meeting and vote your shares in person. |
|
|
|
How may I revoke my
proxy instructions?
|
|
If you vote your shares, and later desire to change your
vote (prior to the Annual Meeting), you may revoke your
proxy instructions by any of the following procedures: |
|
|
|
|
|
1. Send us another signed proxy with a later date; |
|
|
|
|
|
2. Send a letter to our Corporate Secretary revoking your
proxy before your Common Stock has been voted by the persons
named as proxies at the Annual Meeting; or |
|
|
|
|
|
3. Attend the Annual Meeting and vote your shares in person. |
1
|
|
|
How are votes counted?
|
|
The Annual Meeting will be held if
a majority of our outstanding
shares entitled to vote is
represented at the meeting. If you
have returned valid proxy
instructions or attend the meeting
in person, your shares will be
counted for the purpose of
determining whether there is a
quorum, even if you wish to abstain
from voting on some or all matters
introduced at the meeting. If a
quorum is not present, the Annual
Meeting may be adjourned from time
to time until a quorum is obtained. |
|
|
|
|
|
If you give us a proxy without
giving specific voting
instructions, your shares will be
voted by the persons named as
proxies as recommended by the
Board. We are not aware of any
others matters to be presented at
the Annual Meeting except for those
described in this Proxy Statement.
However, if any other matters not
described in this Proxy Statement
are properly presented at the
meeting, the persons named as
proxies will use their own judgment
to determine how to vote your
shares. If the meeting is
adjourned, your shares may be voted
by the persons named as proxies on
the new meeting date as well,
unless you have revoked your proxy
instructions prior to that time. |
|
|
|
What is a broker non-vote?
|
|
A broker non-vote occurs when a
broker or other nominee holding
shares for a beneficial owner does
not vote on a particular proposal
because the broker or other nominee
does not have discretionary voting
power with respect to that item and
has not received instructions from
the beneficial owner. Broker
non-votes are counted as present or
represented for purposes of
determining the presence or absence
of a quorum for the Annual Meeting,
if such shares are otherwise
properly represented at the meeting
in person or by proxy. Broker
non-votes are not counted for
purposes of determining the number
of shares entitled to vote on any
proposal which the broker or other
nominee lacks discretionary
authority. |
|
|
|
|
|
If you are a beneficial shareholder
and your broker holds your shares
in its name, the broker is
permitted to vote your shares on
the election of Directors and
ratification of the appointment of
KPMG LLP as the Companys
independent registered public
accounting firm even if the broker
does not receive voting
instructions from you. Your broker
may not vote your shares on the
proposal relating to the
re-approval of the Cerner
Corporation Performance-based
Compensation Plan absent
instructions from you; without your
voting instructions on this
proposal a broker non-vote will
occur. |
|
|
|
May I attend the Annual Meeting?
|
|
If you were a holder of record on
the record date, March 31, 2006,
you may attend and vote at the
Annual Meeting. If you plan to
attend the Annual Meeting, please
indicate this when you vote. If
you want to vote in person shares
you hold in street name, you will
have to get a proxy in your name
from your bank or broker. |
|
|
|
What vote is required?
|
|
A plurality of the votes cast is
required for the election of
Directors. Therefore, if you do
not vote for a nominee or you elect
to withhold authority to vote for
any nominee on your Proxy Card,
your vote will not count for or
against any nominee. No
shareholder may vote in person or
by proxy for greater than two
nominees at the Annual Meeting.
Shareholders do not have cumulative
voting rights in the election of
Directors. |
|
|
|
|
|
The proposals to ratify the
appointment of KPMG LLP as our
independent registered public
accounting firm and to re-approve
the Cerner Corporation
Performance-based Compensation Plan
will each be adopted upon the
affirmative vote of the majority of
shares voting on the proposal.
Abstentions are treated as votes
Against the proposal. |
2
|
|
|
How does the Board
|
|
The Board recommends a vote: |
recommend that I vote? |
|
|
|
|
|
|
For all nominees for Director; |
|
|
|
|
For the ratification of the appointment
of KPMG LLP as the independent registered
public accounting firm of the Company for 2006;
and |
|
|
|
|
For the re-approval of the Cerner Corporation Performance-based Compensation Plan. |
|
|
|
Who pays the cost of
this proxy solicitation?
|
|
The Company is paying the cost of this proxy
solicitation. We will, upon request, reimburse
brokers, banks and other nominees for their
expenses in sending proxy material to their
principals and obtaining their proxies. We
will solicit proxies by mail, except for any
incidental personal solicitation made by our
Directors, officers and associates, for which
they will not be paid. |
|
|
|
|
|
We have engaged ADP Investor Communication
Services as paid solicitors in connection with
the Annual Meeting. ADP will be paid to
solicit proxies and distribute proxy materials
to nominees, brokers and institutions. The
anticipated cost of such services is
approximately $25,000. |
|
|
|
Who should I call if I
have questions?
|
|
If you have questions about the Annual Meeting
or voting, please call our Corporate Secretary,
Randy Sims, at (816) 201-2556. |
3
INFORMATION CONCERNING DIRECTORS
Our Board consists of eight persons, divided into three classes serving staggered terms of three
years. The terms of our two Class II directors will expire at this years Annual Meeting (if
re-elected, their new terms will expire at the 2009 annual meeting). The terms of the Class I and
Class III Directors will expire at the 2008 and 2007 annual meetings, respectively. The Board has
determined that all six current non-employee members of the Board are independent directors as
required by the Securities and Exchange Commission (SEC) and The NASDAQ Stock Market. The names
of the Companys Directors and information about them are set forth below.
CLASS I
John C. Danforth
(Age 69)
Member of the:
Compensation Committee
Nominating, Governance &
Public Policy Committee
Mr. Danforth was a Director of the Company from May 1996 through June 2004 when he resigned to
serve as Ambassador to the United Nations, where he served from July 2004 through January 2005.
Mr. Danforth was re-appointed by the Board as a Director of the Company in February 2005. Mr.
Danforth represented the State of Missouri in the U.S. Senate for 18 years until 1994 and served as
a Director of The Dow Chemical Company and MetLife, Inc. until June 2004. Mr. Danforth is
presently a partner in the law firm of Bryan Cave LLP; an advisory member of the Board of Trustees
of Eisenhower Medical Center; and, serves as a Director of Greenhill & Co., Inc.
Neal L. Patterson
(Age 56)
Mr. Patterson has been a Director of the Company since 1980 and is a co-founder of the
Company. Mr. Patterson has been Chairman of the Board of Directors and Chief Executive
Officer of the Company for more than five years. Mr. Patterson also served as President of
the Company from March 1999 until August 1999.
William D. Zollars
(Age 58)
Member of the:
Audit Committee
Compensation Committee
Mr. Zollars has been a Director of the Company since May 2005. He is currently the Chairman,
President and Chief Executive Officer of YRC Worldwide, which position he has held since November
1999. Prior to 1999, Mr. Zollars served as President of Yellow Transportation, Inc. from September
1996 through November 1999. From 1994 to 1996, Mr. Zollars was Senior Vice President of Ryder
Integrated Logistics, and prior to that, Mr. Zollars spent time with Eastman Kodak in various
executive positions. Mr. Zollars serves on the boards of the following public companies: YRC
Worldwide, ProLogis and CIGNA Corporation. Mr. Zollars also serves: on the boards of The Midwest
Research Institute, National Association of Manufacturers, Heart of America United Way, American
Trucking Associations, The Civic Council of Greater Kansas City, the American Royal Association,
The Carlson School of Management at the University of Minnesota and the Business Roundtable.
CLASS II
Clifford W. Illig
(Age 55)
Mr. Illig has been a Director of the Company since 1980 and is a co-founder of the Company.
Mr. Illig served as Chief Operating Officer of the Company for more than
five years until October 1998 and as President of the Company for more than five years until March
1999. Mr. Illig has served as Vice Chairman of the Board of Directors since March 1999.
William B. Neaves, Ph.D.
(Age 63)
Member of the:
Audit Committee
Compensation Committee
Nominating, Governance &
Public Policy Committee
(Chairman)
Dr. Neaves has been a Director of the Company since March 2001. Dr. Neaves has been
President, Chief Executive Officer, and member of the Board of Directors of The Stowers
Institute for Medical Research since June 2000. For twenty years prior to 2000, he served in
succession as Dean of Southwestern Graduate School, Dean of Southwestern Medical School, and
Chief Academic Officer and holder of the Wildenthal Distinguished Chair in Biomedical Science
at the University of Texas Southwestern Medical Center. He is presently a member of the Board
of Directors of Midwest Research Institute, the Board of Trustees of Washington University in
St. Louis, and the National Council of the Washington University School of Medicine.
4
CLASS III
Gerald E. Bisbee, Jr., PhD.
(Age 63)
Member of the:
Audit Committee
(Chairman)
Compensation Committee
Nominating, Governance &
Public Policy Committee
Dr. Bisbee has been a Director of the Company since February 1988. Dr. Bisbee is Chairman,
President and Chief Executive Officer of ReGen Biologics, Inc. (ReGen), which develops,
manufactures and markets orthopaedic tissue repair products worldwide. He was a Director of
Aros Corporation (formerly known as APACHE Medical Systems, Inc.) commencing in December 1989,
serving as Chairman of the Board from December 1989 to November 1997 and from December 2000 to
June 2002. He was Chief Executive Officer of Aros from December 1989 to November 1997. Dr.
Bisbee was also appointed Secretary of Aros in December 2000. In June 2002, ReGen and Aros
merged.
Nancy-Ann DeParle
(Age 49)
Member of the:
Audit Committee
Compensation Committee
Ms. DeParle has been a Director of the Company since May 2001. Ms.
DeParle is a Senior Advisor to JPMorgan Partners, LLC and an Adjunct Professor
of Health Care Systems at the Wharton School of the University of Pennsylvania.
She also serves as a Commissioner on the Medicare Payment Advisory Commission
(MedPAC), which advises Congress on Medicare payment and policy issues. She
was Administrator of the Health Care Financing Administration (HCFA, now the
Centers for Medicare and Medicaid Services) from 1997 to October 2000 and a
Fellow of the Institute of Politics and the Interfaculty Health Policy Forum at
Harvard University from October of 2000 to the Spring of 2001. As HCFA
Administrator, Ms. DeParle was a key health policy advisor to President Clinton
and directed the Medicare, Medicaid and State Childrens Health Insurance
programs. Before joining HCFA, she served as Associate Director for Health and
Personnel at the White House Office of Management and Budget from 1993 to 1997.
She has also worked as a lawyer in private practice and served as the
Commissioner of the Tennessee Department of Human Services. Ms. DeParle is a
Director of DaVita, Inc., Guidant Corporation and Triad Hospitals, Inc.
Michael E. Herman
(Age 64)
Member of the:
Compensation Committee
(Chairman)
Mr. Herman has been a Director of the Company since May 1995. He was President of the Kansas City
Royals Baseball Club from 1992 to 2000. He was President of the
Kauffman Foundation from 1985 to 1990 and Chairman of its Finance and Investment Committee from
1990 to 1999. Mr. Herman was the Executive Vice President and Chief Financial Officer of Marion
Laboratories, Inc. from 1974 to 1990. He is a Trustee of Rensselaer Polytechnic Institute and the
University of Chicago Graduate School of Business. Mr. Herman is presently a Director of Santarus,
Inc. and Senomyx, Inc.
5
MEETINGS OF THE BOARD AND COMMITTEES
The Board has established Audit, Compensation and Nominating, Governance & Public Policy
Committees. The Board has adopted a written charter for each of these Committees. The full text
of each charter and the Companys Corporate Governance Guidelines are available on the Companys
website located at www.Cerner.com. The Board does not have an Executive Committee. During 2005,
the Board held four regular meetings, the Audit Committee held eleven meetings, the Compensation
Committee held four meetings and the Nominating, Governance & Public Policy Committee held two
meetings. Each Director attended at least 75% of the total meetings of the Board and the Board
committees on which the Director served during the fiscal year.
The Board has determined that all of the members of each of the Boards three standing committees
are independent as defined under the rules of The NASDAQ Stock Market, including, in the case of
all members of the Audit Committee, the additional independence requirements of Rule 10A-3 under
the Exchange Act. Under applicable NASDAQ rules, a Director of the Company will only qualify as an
independent director if, in the opinion of the Board, that person does not have a relationship
which would interfere with the exercise of independent judgment in carrying out the
responsibilities of a Director. The Board has determined that none of the following Directors has a
relationship which would interfere with the exercise of independent judgment in carrying out the
responsibilities of a Director and that each of these Directors is an independent director as
defined under Rule 4200(a)(15) of The NASDAQ Stock Market Marketplace Rules: Gary E. Bisbee, Jr.,
Ph.D.; John C. Danforth; Nancy-Ann DeParle; Michael E. Herman; William B. Neaves, Ph.D.; and,
William D. Zollars.
Pursuant to the Companys Corporate Governance Guidelines, all Directors who are up for election
are expected to attend the Annual Meeting. All other Directors, barring unforeseen circumstances,
are expected to attend the Annual Meeting as well. All of our current Directors, including the
Directors up for re-election this year, attended the 2005 Annual Meeting of Shareholders.
The independent Directors generally hold executive sessions at each regularly scheduled Board
meeting without management present and may hold additional executive sessions as they determine
appropriate.
Committees of the Board
The Audit Committee assists the Board in fulfilling its responsibilities with respect to our
accounting and financial reporting practices, and in addressing the scope and expense of audit and
related services provided by our independent public accounting firm. The Audit Committee has the
authority to obtain advice and assistance from, and receive appropriate funding from the Company
for, outside legal, accounting or other advisors as the Audit Committee deems necessary to carry
out its duties. The Board has determined that the composition of the Audit Committee, the
attributes of its members and the responsibilities of the Audit Committee, as reflected in its
charter, are in accordance with applicable SEC rules and The NASDAQ Stock Market Marketplace Rules
for audit committees. In particular, all Audit Committee members possess the required level of
financial literacy, at least one member of the Audit Committee meets the current standard of
requisite financial management expertise and the Board has determined that Gerald E. Bisbee, Jr.,
Ph.D, the Chairman of the Audit Committee, is an audit committee financial expert as defined in
Item 401(h) of Regulation S-K of the SEC.
The Compensation Committee reviews and approves our compensation policies and practices,
establishes compensation for Directors, evaluates Mr. Pattersons performance and establishes
compensation accordingly, reviews and approves the compensation of other executive officers, and
approves major changes in our benefit plans and compensation philosophy.
The Nominating, Governance & Public Policy Committee provides assistance and recommendations to the
Board, the Chairman and the Chief Executive Officer of the Company in the areas of: (a) Board
membership nomination, committee membership selection and rotation practices, (b) evaluation of the
overall effectiveness of the Board and review and consideration of developments in corporate
governance practices, and (c) current and emerging political, corporate citizenship and public
policy issues that may affect our business operations, performance or public image. The Chairman
of the Nominating, Governance & Public Policy Committee presides at all executive session meetings
of the independent Directors.
6
Nomination Process and Shareholder Access to Directors
Nominees may be suggested by Directors, members of management, shareholders or, in some cases, by a
third party firm. In identifying and considering candidates for nomination to the Board, the
Nominating, Governance & Public Policy Committee considers, in addition to the requirements set out
in our Corporate Governance Guidelines and the Nominating, Governance & Public Policy Committee
Charter, quality of experience, the needs of the Company and the range of talent and experience
represented on the Board.
In its assessment of each potential candidate, the Nominating, Governance & Public Policy Committee
will conduct a background evaluation and review the nominees: judgment; character and integrity;
experience in business, healthcare, information technology, government and in areas that are
relevant to our global activities; independence; understanding of our business or other related
industries; and, such other factors the Nominating, Governance & Public Policy Committee determines
are pertinent in light of the current needs of the Board. The Nominating, Governance & Public
Policy Committee will also take into account the ability of a Director to devote the time and
effort necessary to fulfill his or her responsibilities. The Nominating, Governance & Public
Policy Committee may use the services of a third-party executive search firm to assist it in
identifying and evaluating possible nominees for Director.
The Nominating, Governance & Public Policy Committee will consider recommendations for
directorships submitted by shareholders. Shareholders who wish the Nominating, Governance & Public
Policy Committee to consider their recommendations for nominees for the position of Director should
submit their recommendations in writing to the Nominating, Governance & Public Policy Committee in
care of the Companys Secretary, Cerner Corporation, 2800 Rockcreek Parkway, North Kansas City,
Missouri 64117. Recommendations by shareholders that are made in accordance with these procedures
will receive the same consideration given to other potential nominees considered by the Nominating,
Governance & Public Policy Committee. In addition, shareholders may submit Director nominations to
the Company in accordance with the procedures described below in Shareholder Proposals.
The Board provides a process for shareholders to send communications to the Board or any of the
individual Directors. Shareholders may send written communications to the Board or any of the
individual Directors c/o Secretary, Cerner Corporation, 2800 Rockcreek Parkway, North Kansas City,
Missouri 64117. All communications will be compiled by our Corporate Secretary and submitted to
the Board or the individual Directors, as applicable, on a periodic basis.
Director Compensation
During 2005, non-employee Directors of the Company received a $25,000 annual cash retainer and
$2,500 for each Board meeting attended, plus reimbursement for expenses incurred in connection with
attendance at Board meetings. The Chairman of the Audit Committee received $2,000 for each Audit
Committee meeting attended as Chairman, the Chairman of the Compensation Committee received $1,600
for each Compensation Committee meeting attended as Chairman, and the Chairman of the Nominating,
Governance & Public Policy Committee received $1,200 for each such Committee meeting he attended as
Chairman. Each Committee member received $1,000 for each Committee meeting attended. All Chairman
and Committee member fees were paid at fifty percent (50%) of such rates for attendance at
telephonic Committee meetings. During 2005, cash payments, excluding expense reimbursements, were
$60,000 to Dr. Bisbee, $46,500 to Ms. DeParle, $9,750 to Jeff C. Goldsmith (who was a Director for
the Company through May 27, 2005), $41,400 to Mr. Herman, $50,100 to Mr. Neaves and $32,250 to Mr.
Zollars. Mr. Danforth was entitled to receive $37,000 cash compensation in 2005 based on the
above described annual cash retainer and Board and Committee meetings fees; however, in lieu of
cash, Mr. Danforth is compensated in the form of usage of planes owned by or under contract to the
Company.
Each non-employee Director that is appointed or elected to the Board on or after May 2004, receives
a grant of 2,500 shares of restricted stock upon such initial appointment/election that will vest
in equal amounts each year over a three year term, provided the individual remains a Director of
the Company. John C. Danforth and William D. Zollars each received their initial
appointment/election grant of 2,500 shares of restricted stock in April 2005 and June 2005,
respectively. These grants will vest pro rata over a three year period as set forth above.
7
Each non-employee Director that is elected or re-elected to the Board on or after May 2004 also
receives a grant of 2,500 shares of restricted stock of the Company for each year of service on the
Board. In June 2005, pursuant to this Board compensation program, 2,500 shares of restricted stock
of the Company were granted to each of Mr. Bisbee, Mr. Danforth, Ms. DeParle, Mr. Herman and Mr.
Zollars. The restricted stock grants will vest in May 2006 at the completion of the one year of
Board services for which they were granted.
AUDIT COMMITTEE REPORT
Notwithstanding anything to the contrary set forth in any of the Companys filings under the
Securities Act of 1933 or the Securities Exchange Act of 1934, the following report of the Audit
Committee shall not be incorporated by reference into any such filings and shall not otherwise be
deemed to be soliciting material or filed under such Acts.
The Audit Committee of the Company is currently composed of four independent members of the Board
of Directors (all of whom meet the independence requirements of the SEC and The NASDAQ Stock
Market) and operates under a written charter adopted by the Board of Directors. The Audit
Committee appoints and retains the Companys independent registered public accounting firm. The
selection is subsequently submitted to the shareholders of the Company for ratification.
Management is responsible for the Companys internal controls and the financial reporting process.
The independent registered public accounting firm, KPMG LLP, is responsible for performing an
independent audit of the Companys consolidated financial statements and issuing an opinion on the
conformity of those audited consolidated financial statements with U. S. generally accepted
accounting principles and on the effectiveness of the Companys internal control over financial
reporting, and managements assessment of the internal control over financial reporting. The Audit
Committees responsibility is to monitor and oversee these processes and to report to the Board of
Directors on its findings.
In this context, the Audit Committee has met and held discussions with management and the
independent registered public accounting firm. Management represented to the Audit Committee that
the Companys consolidated financial statements were prepared in accordance with U.S. generally
accepted accounting principles, and the Audit Committee has reviewed and discussed the consolidated
financial statements with management and the independent registered public accounting firm. The
Audit Committee discussed with the independent registered public accounting firm matters required
to be discussed by Statement on Auditing Standards No. 61 (Communications with Audit Committees).
The Companys independent registered public accounting firm also provided to the Audit Committee
the written disclosures and letter required by Independence Standards Board Standard No. 1
(Independence Discussions with Audit Committees), and the Audit Committee discussed with the
independent registered public accounting firm that firms independence.
Based upon the Audit Committees discussion with management and the independent registered public
accounting firm and the Audit Committees review of the representation of management and the report
of the independent registered public accounting firm to the Audit Committee, the Audit Committee
recommended that the Board of Directors include the audited consolidated financial statements in
the Companys Annual Report on Form 10-K for the year ended December 31, 2005 to be filed with the
Securities and Exchange Commission.
Members of the Audit Committee:
Gerald E. Bisbee, Jr., Ph.D.
Nancy-Ann DeParle
William B. Neaves, Ph.D.
William D. Zollars
8
Guidelines of Cerner Corporations Audit Committee
for Pre-Approval of Independent Auditor Services
The Audit Committee has adopted the following guidelines regarding the engagement of our
independent registered public accounting firm to perform services for the Company:
For audit services (including statutory audit engagements as required under local country laws) and
audit-related services, the independent auditor will provide the Audit Committee with an engagement
letter during the first quarter of each year outlining the scope of audit and audit-related
services proposed to be performed during the fiscal year. If agreed to by the Audit Committee,
this engagement letter will be formally accepted by the Audit Committee at either its March or May
Committee meeting. The Audit Committee will approve, if necessary, any changes in the terms,
conditions and fees resulting from changes in audit scope, Company structure or other matters.
The independent registered public accounting firm will submit to the Audit Committee for approval
an audit services fee proposal with the engagement letter.
For any permissible non-audit services, the independent registered public accounting firm will
provide the Audit Committee with a detailed scope of service description and fee range. Each
non-audit service must be separately pre-approved by the Audit Committee. Our management and the
independent registered public accounting firm will each confirm to the Audit Committee that any
non-audit services for which pre-approval is requested are permissible under all applicable legal
requirements.
To ensure prompt handling of unexpected matters, the Audit Committee delegates to the Chair of the
Committee the authority to amend or modify the scope of pre-approved permissible audit,
audit-related or non-audit services and the fees related thereto. Upon receiving an unforeseen
request for audit, audit-related or non-audit services or a change in the fee range, the
independent registered public accounting firm will advise our management; our management will
request pre-approval for such change in audit, audit-related or non-audit services or fees from the
Chair of the Audit Committee. The Audit Committee Chair will report on all action taken with
respect to pre-approval of audit, audit-related or non-audit services and fees to the Audit
Committee at the next Committee meeting. With respect to any such pre-approval of non-audit
services, our management and the independent registered public accounting firm will each confirm to
the Audit Committee Chair that such non-audit services are permissible under all applicable legal
requirements.
With respect to each proposed pre-approved service, the independent registered public accounting
firm will provide sufficient detail in the description to ensure that the Audit Committee (or
Chairman, as applicable) knows precisely what services it is being asked to pre-approve so that it
can make a well-reasoned assessment of the impact of the service on the registered public
accounting firms independence.
The independent registered public accounting firm must ensure that all audit and non-audit services
provided to the Company have been approved by the Audit Committee.
9
COMPENSATION COMMITTEE REPORT
Notwithstanding anything to the contrary set forth in any of the Companys filings under the
Securities Act of 1933 or the Securities Exchange Act of 1934, the following report of the
Compensation Committee shall not be incorporated by reference into any such filings and shall not
otherwise be deemed to be soliciting material or filed under such Acts.
The Compensation Committee of the Board of Directors (the Compensation Committee) reviews and
approves the Companys compensation policies and practices, establishes compensation for Directors,
evaluates Mr. Pattersons performance and establishes compensation accordingly, reviews and
approves the compensation of the other executive officers of the Company, and approves major
changes in the Companys benefit plans and compensation philosophy.
The Compensation Committee is composed of the individuals listed below, each of whom is independent
within the meaning of The NASDAQ Stock Market listing standards. The Compensation Committee
utilizes internal resources in the Company to help it carry out its responsibilities and has
utilized an independent compensation consultant for more than five years to assist it in fulfilling
its responsibility on an as needed basis. In 2005, an independent consultant was engaged to: i)
prepare an analysis of CEO compensation; ii) provide equity compensation recommendations in light
of stock option expensing requirements in 2006; and, iii) advise the Compensation Committee and the
Company regarding executive compensation programs generally and provide advice on trends in
compensation.
Compensation Strategy/Objectives
The Companys compensation strategy is to offer competitive compensation packages to attract,
motivate and reward qualified associates who contribute significant value to Cerner. This
philosophy is linked to Cerners performance management philosophy that is designed to identify and
reward associate performance through compensation. The Companys strategy is to pay in aggregate
at the median (50th percentile) within its peer group with top performers able to earn within the
top quartile (75th percentile). The Compensation Committee defines its peer group annually by
analyzing companies whose annual revenue, total shareholder return (one year and three year) and
market capitalization are similar to that of the Company. The Compensation Committee also utilizes
third party executive compensation survey data. The Companys compensation program is designed to
reward performance, such as attaining goals, business results, leadership, strong relationships
with clients, and is not based on rewarding seniority. Cerner believes that this strategy allows
the Company to attract qualified candidates and maintain a reasonable business model.
Compensation Elements
Compensation for Cerners executives includes: i) base salary; ii) performance-based cash incentive
compensation; and, iii) long-term incentive plan compensation. To provide incentives, a
significant portion of the executive compensation is at-risk and tied to individual and Company
performance. The Company provides its executive officers with relatively limited perquisites that
the Compensation Committee believes are reasonable and in the best interest of the Company and its
shareholders.
(i) base salary: The Compensation Committee sets the salary levels of the Chief Executive Officer
and reviews recommendations and approves the salary of the Companys Section 16 Insiders
(executive officers) during the first quarter of each calendar year. The salary is based on the
duties and responsibilities that the Company expects each executive to discharge during the current
year and upon the executives performance during the previous year. The Company also performs
external market comparisons for the executive officers, relative to industry-specific peers, based
on individual job responsibility. This comparison data is used to help ensure that the proposed
executive officers compensation is within reasonable market comparison ranges and in line with the
Companys compensation strategy as detailed above.
(ii) performance-based cash incentive compensation: Cerners performance-based cash incentive
compensation is designed to provide a meaningful incentive on both a quarterly and annual basis to
key associates and executives of the Company and to motivate them to assist the Company in
achieving ambitious, attainable, short-term goals. Individual payments will vary, depending upon
individual performance and, in some cases, business unit operational
10
achievements. The Company grants such cash incentive bonuses pursuant to a shareholder
approved performance-based compensation plan.
The performance-based compensation plan is administered by the Compensation Committee, which
establishes performance targets, eligibility and range of incentive amounts. Under the general
feature of the plan, for which the Companys executive officers are not eligible, the performance
targets may vary from participant to participant and may include targets such as earnings per
share, profit margins on a contract-by-contract basis, cash collections and achievement of
subsidiary or division operating goals. Adjustments may be made during the year as appropriate,
for example, to take account of unusual or unanticipated Company or industry-wide development.
Final determination of the amounts to be paid to a participant under the general feature of the
plan may also be adjusted upward or downward depending upon subjective evaluations by the
participants executive or manager.
Under the executive feature of the performance-based compensation plan, for which the Companys
executive officers are eligible, the Committee establishes targets prior to or at the beginning of
the performance period and for which measurement of the achievement of such targets can be, and
are, determined under pre-established objective formulas. The Committee may select targets such as
earnings per share, operating margins, contract margins or other targets specifically permitted by
the executive feature of the plan. Once established, the targets under the executive feature of
the plan may not generally be changed. Bonuses awarded to executive officers under the executive
feature of the plan may only be adjusted downward, based upon a subjective analysis of the
executive officers overall performance, from the maximum bonus amount available to such executive
officer.
For the Companys Chief Executive Officer, Mr. Patterson, the performance targets during 2005
consisted of, and in 2006 will again consist of, earnings per share and cash collections as a
measure of client satisfaction. During 2005, the performance targets for the other executive
officers consisted primarily of earnings per share and cash collections as a measure of client
satisfaction and, for executive officers with sales-focused roles and/or operational
responsibility, the targets included contract and operating margins and operational metrics such as
service level request resolution and client systems uptime. The Committee has approved
substantially the same type of performance targets for the executive officers for 2006.
As a result of the Companys 2005 performance, the Company paid cash bonuses to its executive
officers under the performance-based compensation plan. The aggregate incentives paid with respect
to fiscal 2005 to the Companys executive officers averaged 75% of the maximum cash incentive
opportunity available for all such eligible executive officers.
(iii) long-term incentive plan compensation: Cerners shareholder approved Long-Term Incentive
Plans F and G are designed to drive long-term shareholder value and retain valuable associates by:
a) positioning Cerner competitively as an employer; b) creating an incentive for associates to
contribute to sustained, long-term growth in the Companys performance; c) creating a mutuality of
interest between the Companys associates and shareholders; and, d) providing financial incentives
for associates. The program encourages associate stock ownership in an effort to align associates
interests with shareholders thereby encouraging extraordinary effort on behalf of the Companys
associates. The Company awards under Long-Term Incentive Plans F and G have historically been in
the form of options and/or restricted stock.
The Committee approves an annual grant target aggregate value for all eligible associates as well
as target grant ranges based on level of corporate responsibility and associate performance. The
Committee also approves specific grant levels for executive officers, generally on an annual basis.
Stock option grants are typically made to an executive upon their commencement of employment with
the Company. Executives are eligible for additional stock option grants on an annual basis as
their individual and Company performance warrants. Grants are also made to the top 20% performers
below the executive level based upon individual achievements.
Grants of non-qualified stock options are made at an exercise price that is equal to the market
price of the Companys common stock at the time of grant. The size of the grant is based on the
individuals level of responsibility, the individuals contributions to the achievement of the
Companys financial and strategic objectives, anticipated future contributions to the Company and
the amount, exercise price and term of options already held by the individual. Grants vest over a
five-year term with 40% vesting at the end of the second year and 20% each year thereafter.
11
In accordance with the Companys overall compensation philosophy and view of appropriate total
compensation, and, in particular, to further the long-term perspective that the Company believes is
necessary for the Companys future success, the Company made stock option awards to its executive
officers, including the CEO, in June 2005 under the Companys 2001 Long-Term Incentive Plan F. As
explained below, an additional grant was made to the CEO in September 2005. Individual grants for
executive officers were based on job responsibilities, performance during 2004 and contributions to
the achievement of the Companys financial and strategic objectives, anticipated future
contributions to the Company and the amount, exercise price and term of options already held by the
individual. The Committee has approved similar grants to certain of the Companys executive
officers for 2006, which stock options were granted on March 9, 2006.
Aligning Pay with Performance
During 2005, the Companys management team continued practices established to closely link pay to
performance. A quarterly performance review process was used to provide quarterly feedback to
executives on their performance and attainment of Company goals. Under this program, executives
whose performance was evaluated as being in the bottom 20% of all executives are not generally
eligible for pay increases or additional stock option grants. In addition, a portion or all of
such executives performance-based incentive compensation award, if earned, may be reduced or
eliminated.
Compensation of the Chief Executive Officer
The Compensation Committee determines compensation for the Chief Executive Officer using the same
criteria it uses for other executive officers. The Compensation Committee meets each year in
executive session to evaluate the performance of the Chief Executive Officer and determine his
appropriate compensation package including base salary, performance-based cash incentive
compensation and long-term incentive compensation. As noted previously, an independent
compensation consultant was engaged in 2005 to conduct a study of competitive compensation for
chief executive officers in Cerners peer group based on annual revenue, market capitalization,
total shareholder return (one year and three year) and growth of earnings before interest, taxes,
depreciation and amortization (EBITDA). The analysis indicated that the total compensation for the
Companys Chief Executive Officer, Neal Patterson, generally ranked low compared to the
compensation of the other chief executive officers in such peer group while the Company generally
ranked high compared to such peer group of companies based on the listed size and performance
measures. Partly as a result of such analysis and also as a result of the Companys continued
strong performance, the Committee increased Mr. Pattersons base salary in May of 2005 and issued
42,000 stock options (pre-stock split of January 10, 2006) in September of 2005 (all in addition to
the annual salary adjustment and stock option grant awarded to Mr. Patterson by the Committee in
March and June of 2005, respectively).
In 2005, Mr. Patterson earned total cash compensation of $1,708,094 which included $761,058 in base
salary, $889,818 in payments earned under the Companys performance-based incentive plan, and a
total of $57,218 resulting from (i) private use of the corporate jet ($48,381), (ii) Company
provided life insurance ($437), (iii) 401(k) match ($4,200), and (iv) the second tier 401(k) match
($4,200). In addition, Mr. Patterson was granted 82,000 stock options (pre-stock split of January
10, 2006) at the market price on the date of the grant (40,000 granted at an exercise price of
$62.81 on June 3, and 42,000 granted at an exercise price of $82.25 on September 16, 2005; all such
amounts and exercise prices reflecting amounts and prices prior to adjustment for the January 10,
2006 stock split). Mr. Patterson earned approximately 76% of the maximum $1,166,344 amount
available to him under the performance-based incentive plan during 2005. Base salary for Mr.
Patterson for 2006 has been set at $865,000 and the maximum performance-based incentive bonus level
has been set at $1,517,141. The 2006 base salary became effective April 2, 2006.
The Company entered into an employment agreement with Neal Patterson dated November 10, 2005. The
agreement provides for Mr. Patterson to continue to serve as the Companys Chief Executive Officer
and as the Chairman of the Board of Directors, reporting directly to the Board of Directors, with a
base salary, specified use of the Companys airplane, and a potential bonus, all to be determined
by the Board of Directors.
Deductibility of Executive Compensation
Section 162(m) of the Internal Revenue Code generally disallows a federal income tax deduction to a
public company for compensation over $1 million per fiscal year paid to a companys chief executive
officer and its four
12
other most highly compensated executive officers serving at the end of that
year. Not subject to the deductibility limit, however, is compensation that qualifies as
performance-based compensation. A Company objective is to maximize the deductibility of
compensation under Section 162(m) to the extent doing so is reasonable and consistent with Company
strategies and goals. Gains on exercises of stock options awarded under Long-Term Incentive Plans
and performance-based cash incentive compensation awarded under a plan approved by the Companys
shareholders are considered to be performance-based compensation not subject to the Section
162(m) deductibility limit. The Compensation Committee may from time to time approve compensation
that is not deductible under this Section.
Members of the Compensation Committee:
Gerald E. Bisbee, Jr., Ph.D.
John C. Danforth
Nancy-Ann DeParle
Michael E. Herman
William B. Neaves, Ph.D.
William D. Zollars
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
None our Directors is an executive officer of a public company of which a Company executive officer
is a director. Two of our Directors, Gerald E. Bisbee, Jr., Ph.D. and John C. Danforth, have an
interest in reportable transactions as set forth under the section in this Proxy titled Certain
Transactions.
NOMINATING, GOVERNANCE & PUBLIC POLICY COMMITTEE REPORT
The Nominating, Governance & Public Policy Committee of the Company is currently composed of three
independent members of the Board of Directors (all of whom meet the applicable independence
requirements of the SEC and The NASDAQ Stock Market) and operates under a written charter adopted
by the Board of Directors, which charter is available for review on the Companys website at
www.Cerner.com under: About Cerner/Corporate Governance.
The Nominating, Governance & Public Policy Committee is appointed by the Board to provide
assistance to the Board, the Chairman and the CEO of the Company in the areas of: (a) Board
membership nomination, (b) committee membership selection and rotation practices, (c) evaluation of
the overall effectiveness of the Board, and (d) review and consideration of developments in
corporate governance practices and current and emerging political, corporate citizenship and public
policy issues that may affect the business operations, performance or public image of the Company.
The Committees goal is to assure that the composition, practices and operation of the Board
contribute to value creation and effective representation of the Companys shareholders and to
foster Cerners commitment to operate its business worldwide in a manner consistent with the
rapidly changing demands of society.
In 2005, the Nominating, Governance & Public Policy Committee: updated the Companys Corporate
Governance Guidelines, which are available for review on the
Companys website at www.Cerner.com
under: About Cerner/Corporate Governance; conducted a self-evaluation of the Board and Board
committees; reviewed and recommended Committee member appointments; and, educated itself with
respect to the content and operation of the Companys Corporate Policies and Compliance Programs.
The Nominating, Governance & Public Policy Committee also reviewed director candidates in
accordance with its charter and pursuant to that review, recommended the director candidates listed
in this Proxy as being the nominees best suited to serve the needs of the Company.
Members of the Nominating, Governance & Public Policy Committee:
Gerald E. Bisbee, Jr., Ph.D.
John C. Danforth
William B. Neaves, Ph.D.
13
EXECUTIVE COMPENSATION
The following table sets forth certain information with respect to our Chief Executive Officer and
our four most highly compensated executive officers for the fiscal year ended December 31, 2005.
Summary Compensation Table
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-Term |
|
|
|
|
|
|
|
|
|
|
Annual
Compensation |
|
|
Compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Annual |
|
|
Number of |
|
|
|
Name and Principal |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation($) |
|
|
Stock Options |
|
|
All Other |
Position |
|
Fiscal Year |
|
|
Salary($)(1) |
|
Bonus($) |
|
(2) |
|
|
Granted |
|
|
Compensation (3) |
|
|
|
|
|
|
|
|
|
|
Neal L. Patterson |
|
|
2005 |
|
|
|
|
761,058 |
|
|
|
889,818 |
|
|
|
48,381 |
|
|
|
|
164,000 |
|
|
|
|
8,837 |
|
Chairman of
the Board of Directors And Chief Executive
Officer |
|
|
2004 |
|
|
|
|
650,000 |
|
|
|
634,644 |
|
|
|
62,400 |
|
|
|
|
60,000 |
|
|
|
|
8,468 |
|
|
|
|
2003 |
|
|
|
|
569,903 |
|
|
|
137,579 |
|
|
|
|
|
|
|
|
50,000 |
|
|
|
|
4,363 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earl H. Devanny, III |
|
|
2005 |
|
|
|
|
418,269 |
|
|
|
460,932 |
|
|
|
|
|
|
|
|
35,000 |
|
|
|
|
8,766 |
|
President |
|
|
2004 |
|
|
|
|
410,000 |
|
|
|
363,000 |
|
|
|
|
|
|
|
|
8,000 |
|
|
|
|
8,529 |
|
|
|
|
2003 |
|
|
|
|
415,192 |
|
|
|
92,893 |
|
|
|
|
|
|
|
|
30,000 |
|
|
|
|
4,289 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Paul M. Black |
|
|
2005 |
|
|
|
|
383,077 |
|
|
|
443,441 |
|
|
|
|
|
|
|
|
35,000 |
|
|
|
|
8,736 |
|
Executive Vice President |
|
|
2004 |
|
|
|
|
345,000 |
|
|
|
412,221 |
|
|
|
|
|
|
|
|
36,000 |
|
|
|
|
8,478 |
|
|
|
|
2003 |
|
|
|
|
328,270 |
|
|
|
248,910 |
|
|
|
|
|
|
|
|
60,000 |
|
|
|
|
4,221 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Douglas M. Krebs |
|
|
2005 |
|
|
|
|
283,269 |
|
|
|
414,235 |
|
|
|
393,571 |
|
|
|
|
|
|
|
|
|
8,650 |
|
Sr. Vice President |
|
|
2004 |
|
|
|
|
271,249 |
|
|
|
287,187 |
|
|
|
191,326 |
|
|
|
|
|
|
|
|
|
8,420 |
|
|
|
|
2003 |
|
|
|
|
260,962 |
|
|
|
137,204 |
|
|
|
291,638 |
|
|
|
|
|
|
|
|
|
4,169 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jeff Townsend |
|
|
2005 |
|
|
|
|
316,346 |
|
|
|
297,010 |
|
|
|
|
|
|
|
|
30,000 |
|
|
|
|
8,675 |
|
Executive Vice President |
|
|
2004 |
|
|
|
|
271,249 |
|
|
|
247,407 |
|
|
|
|
|
|
|
|
24,000 |
|
|
|
|
8,420 |
|
|
|
|
2003 |
|
|
|
|
248,654 |
|
|
|
68,160 |
|
|
|
|
|
|
|
|
20,000 |
|
|
|
|
3,960 |
|
|
|
|
(1) |
|
2003 salary represents 53 weeks due to the Companys fiscal year being one week longer in
2003. |
|
(2) |
|
This column includes the aggregate incremental cost to Cerner of providing personal benefits
to the named executive officers for the last three years. The personal benefits included in
this column are personal use of company aircraft for Mr. Patterson and benefits related to an
expatriate assignment for Mr. Krebs. The amounts reported in this column that represent at
least 25% of the total amount of Other Annual Compensation for the executive officers are:
Mr. Patterson personal use of company aircraft in the amount of $48,381 in 2005 and $62,400
in 2004; and, Mr. Krebs tuition related expenses ($57,655 in 2004), tax equalization
payments ($175,573 in 2005 and $83,327 in 2003) and moving expenses ($74,460 in 2003), all
related to his expatriate assignment. The $175,573 tax equalization payments for Mr. Krebs in
2005 includes tax equalization payments made in 2005 for tax years 2003 2005. |
|
(3) |
|
Includes Company matching contributions and discretionary profit-based allocations to the
named individuals account pursuant to the Cerner Corporation 401(k) Retirement Plan and
premiums paid by the Company on group term life insurance. |
14
Stock Option Plans
The following table reports information with respect to the award of stock options during the year
ended December 31, 2005 for each of our named executive officers in the Summary Compensation Table
(all numbers have been adjusted for the stock-split of January 10, 2006):
Option Grants In Last Fiscal Year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of |
|
|
Percent of total |
|
|
|
|
|
|
|
|
|
|
|
|
|
securities |
|
|
options granted to |
|
|
Exercise |
|
|
|
|
|
|
Grant Date |
|
|
|
underlying options |
|
|
employees |
|
|
in price |
|
|
Expiration |
|
|
present value ($) |
|
Name |
|
granted (#) |
|
|
fiscal year |
|
|
($/Sh)(1) |
|
|
Date |
|
|
(2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Neal L. Patterson |
|
|
80,000 |
|
|
|
6.0 |
|
|
|
31.41 |
|
|
|
6/3/15 |
|
|
|
1,344,984 |
|
|
|
|
84,000 |
|
|
|
6.3 |
|
|
|
41.13 |
|
|
|
9/16/15 |
|
|
|
1,795,609 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earl H. Devanny, III |
|
|
35,000 |
|
|
|
2.6 |
|
|
|
31.41 |
|
|
|
6/3/15 |
|
|
|
588,431 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Paul M. Black |
|
|
35,000 |
|
|
|
2.6 |
|
|
|
31.41 |
|
|
|
6/3/15 |
|
|
|
588,431 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Douglas M. Krebs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jeffrey A. Townsend |
|
|
30,000 |
|
|
|
2.2 |
|
|
|
31.41 |
|
|
|
6/3/15 |
|
|
|
504,369 |
|
|
|
|
(1) |
|
These options were issued at a price that was equal to the market value of the Companys Common
Stock on the date of grant. The options vest and become exercisable in varying amounts per year
over a period of five years from the date of the grant, assuming the optionee remains an employee
of the Company. |
|
(2) |
|
The grant date present value was calculated using the Black-Scholes option pricing model with
the following weighted average assumptions: expected dividend yield of zero percent; expected
stock volatility of 45.4%; risk-free interest rate of 4.3%; and expected years until exercise of
6.6 years for each option. |
15
Aggregated Option Exercises In Last Fiscal Year and December 31, 2005 Option Values(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities |
|
|
|
|
|
|
|
|
|
|
|
|
Underlying Unexercised |
|
Value of Unexercised |
|
|
|
|
|
|
|
|
|
|
Options at December 31, |
|
In-the-Money Options |
|
|
Shares |
|
|
|
|
|
2005 (#) |
|
at December 31, 2005 ($) |
|
|
Acquired on |
|
Value |
|
Exercisable/Unexercisable |
|
Exercisable/ |
Name |
|
Exercise (#) |
|
Realized ($) |
|
(2) |
|
Unexercisable (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Neal L. Patterson |
|
|
|
|
|
|
|
|
|
|
700,000/289,000 |
|
|
|
20,857,575/4,782,925 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earl H. Devanny, III |
|
|
86,358 |
|
|
|
2,348,044 |
|
|
|
97,000/179,000 |
|
|
|
2,533,860/4,536,145 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Paul M. Black |
|
|
71,300 |
|
|
|
1,663,159 |
|
|
|
/202,964 |
|
|
|
/5,175,111 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Douglas M. Krebs |
|
|
65,500 |
|
|
|
1,415,924 |
|
|
|
28,168/63,132 |
|
|
|
653,251/1,732,363 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jeffrey A. Townsend |
|
|
45,480 |
|
|
|
1,514,327 |
|
|
|
96,308/115,912 |
|
|
|
2,948,271/2,991,132 |
|
|
|
|
(1) |
|
All numbers have been adjusted for the stock-split of January 10, 2006. |
|
(2) |
|
The numbers in the column headed Number of Securities Underlying Unexercised Options at
December 31, 2005 and the dollar amounts in the column headed Value of Unexercised In-the-Money
Options at December 31, 2005 reflect (a) the number of shares of the Companys Common Stock into
which options are exercisable and unexercisable and (b) the difference between the market value on
December 31, 2005 of such shares of Common Stock and the exercise price of the options. |
Employment Contracts, Termination of Employment and Change-of-Control Arrangements
We have entered into at-will employment agreements with each of our named executive officers.
Under these agreements, each executive agrees not to compete with us during the executives
employment with us and for two years thereafter; not to solicit any of our employees, consultants
or client employees to terminate their relationship with us (or our clients) during the executives
employment with us and for two years thereafter; and to protect our confidential business
information. Each executive also assigns to us any intellectual property rights he may otherwise
have to any discoveries, inventions or improvements related to our business made while in our
employ or within one year thereafter.
Our Severance Pay Plan, which applies to all of U.S. based permanent, full-time salaried employees,
offers severance pay upon: (i) certain termination without cause events, which severance benefits
will range from two (2) weeks to fifty-two (52) weeks (depending on the employees role and tenure)
of such employees annual base salary and contingent upon the employee satisfying certain
conditions, including without limitation the execution of a severance and release agreement with
the Company providing for a complete release of all present and future claims by the eligible
employee; or (ii) qualifying terminations or resignations for Good Reason following a Change in
Control, which severance benefits will be paid at 1.5 times the calculated weekly severance
eligibility based on role and tenure and will include both base salary and average cash bonus.
Two of our named executive officers are entitled to severance payments other than as set forth in
our Severance Pay Plan; these are: i) Trace Devanny, the Companys president, has an agreement
with the Company to receive severance, if he is terminated by the Company without cause, up to a
period of two years; and, ii) Neal Patterson, the Companys chief executive officer, whose
severance agreement with the Company is disclosed immediately below.
The material terms of the employment agreement with Neal Patterson are as follows:
i) effective as of November 10, 2005;
ii) perpetual term, at-will employment;
16
iii) an annual base salary, specified use of the Companys airplane and a potential bonus as
determined annually by the Board;
iv) termination by the Company without Cause or if Mr. Patterson resigns with Good Reason or
is terminated without Cause within twelve months after the date a Change in Control of the Company
becomes effective, entitles Mr. Patterson to receive: (a) three years base salary; (b) three times
the average annual cash bonus received during the prior three year period; and, (c) health benefits
for a three-year period following the termination, all subject to execution of a severance
agreement containing normal and customary provisions, including but not limited to, a release of
the Company from any employment related claims;
v) upon a termination of employment of Mr. Patterson by the Company without Cause, equity
incentive awards granted after the date of the Agreement that would have vested during the three
year period following such termination shall vest immediately. Upon a Change in Control, 50% of
each equity incentive award granted after June 1, 2005 and prior to the date the Change in Control
becomes effective that has not vested will become vested on the date the Change in Control becomes
effective; and the remaining 50% will continue to vest according to their vesting schedule, unless
Mr. Pattersons employment is terminated without Cause or Mr. Patterson resigns with Good Reason
within twelve months following the date of the Change in Control, in which case 100% of such equity
incentive awards will vest upon the effective date of such termination or resignation with Good
Reason;
vi) Agreement also contains: (a) an assignment provision wherein Mr. Patterson will assign all
New Solutions and Ideas to the Company; (b) a non-disclosure provision that survives in perpetuity;
(c) non-competition and non-solicitation provisions that are effective during the term of Mr.
Pattersons employment and for two years following termination of employment, for any reason, with
the Company; and, (d) a general indemnification provision by Mr. Patterson and the Company.
CERTAIN TRANSACTIONS
The Company leases an airplane from a company owned by Neal L. Patterson and Clifford W. Illig. In
2005, the airplane was leased on a per mile basis with no minimum usage guarantee. The lease rate
is believed to approximate fair market value for this type of aircraft. During 2005, the Company
paid an aggregate of $812,000 for rental of the airplane. The airplane is used principally by Mr.
Devanny and Mr. Black to increase the number of client visits each can make and to reduce the
physical strain of their heavy travel schedules. The Company intends to continue the use of the
airplane in 2006.
During 2005 and in 2006, the Company retained and intends to retain the law firm of Bryan Cave LLP
for certain outside legal services. John C. Danforth, one of the Companys Board members, is a
partner at Bryan Cave LLP. The Company has no other relationship with Bryan Cave LLP other than
the attorney-client relationship. The dollar amount of the fees paid in 2005 and to be paid in
2006 does not and is not expected to exceed 5% of the law firms gross revenues for each respective
year. Mr. Danforth is a member of the Compensation Committee; however, he does not participate in
executive officer equity grants or performance-based compensation plan decisions or actions
undertaken by the Compensation Committee. Such matters are handled by the Stock Option and
Performance-based Compensation Plan Subcommittee.
The Company participates in the Health Management Academy, an industry-wide education forum,
together with over 90 competitors, clients and potential clients of the Company. Gerald E. Bisbee,
Jr., Ph.D., one of the Companys Board members, owns approximately 50% of the common stock of
Health Management Academy. The total amount of fees paid by the Company in 2005 to the Health
Management Academy was $123,000. The Company intends to continue its participation in the Health
Management Academy in 2006. Mr. Bisbee is a member of the Compensation Committee; however, he does
not participate in executive officer equity grants or performance-based compensation plan decisions
or actions undertaken by the Compensation Committee. Such matters are handled by the Stock Option
and Performance-based Compensation Plan Subcommittee.
Certain executive officers have immediate family members who are employed by the Company. The
compensation of each such family member was established by the Company in accordance with the
Companys employment and compensation practices applicable to employees with equivalent
qualifications, experience, responsibilities and holding similar positions. Michael R. Nill, the
brother of Julia M. Wilson, an executive officer of the Company, is
employed by the Company as Vice President, Technical Architecture. Mr. Nills aggregate
compensation for the
17
fiscal year 2005 was $513,570. His compensation is not subject to approval by
the Board of Directors. On June 3, 2005, Mr. Nill was awarded options under the Companys Stock
Option Plan F to purchase 12,500 shares of the Companys Common Stock at an exercise price of
$62.81 per share, which was the closing price of the Companys Common Stock on the date the options
were granted (all amounts are pre stock-split on January 10, 2006). The options granted to Mr.
Nill vest at various amounts over a period of five years. Dr. David Nill, the brother of Julia M.
Wilson, an executive officer of the Company, is employed by Cerner Health Connections, Inc. (a
wholly-owned subsidiary of the Company) as Clinic Physician. Dr. Nill was hired on a full-time
basis effective March 5, 2006 with a base salary of $150,000. Dr. Nills compensation is not
subject to approval by the Board of Directors.
The Company believes that these various relationships and transactions were reasonable and in the
best interests of the Company.
STOCK PRICE PERFORMANCE GRAPH
The following graph presents a comparison for the five-year period ended December 31, 2005 of the
performance of the Common Stock of the Company with the Nasdaq Composite Index (US Companies) (as
calculated by The Center for Research in Security Prices) and the Nasdaq Computer/Data Processing
Group (as calculated by The Center for Research in Security Prices):
Comparison
of 5 Year Cumulative Total Return
The above comparison assumes $100 was invested on December 31, 2000 in Common Stock of the Company
and in each of the foregoing indices and assumes reinvestment of dividends. The results of each
component issuer of each group are weighted according to such issuers stock market capitalization
at the beginning of each year.
18
COMPLIANCE WITH SECTION 16(a) OF
THE SECURITIES EXCHANGE ACT OF 1934
Section 16(a) of the Securities Exchange Act of 1934 requires our Directors, executive officers and
persons who own more than ten percent of a registered class of our equity securities to file with
the SEC initial reports of ownership and reports of changes in ownership of Common Stock and other
equity securities of the Company. Executive officers, Directors and holders of ten percent or more
of our equity securities are required to furnish us with copies of all Section 16(a) reports they
file.
Based solely on review of the copies of such reports furnished to us or written representations
that no other reports were required, we believe that during the fiscal year ended December 31, 2005
all Section 16(a) filing requirements applicable to our executive officers, Directors and holders
of ten percent or more of our equity securities were complied with, except for four exceptions:
|
(1) |
|
Paul Black, Trace Devanny, Dick Flanigan, Doug Krebs, Marc Naughton, Neal
Patterson, Randy Sims and Mike Valentine filed their 2005 Form 5s on February 16, 2005,
which included the late reporting of their Annual Statement of Changes in Beneficial
Ownership of Securities. Last minute changes required to be made to the Form 5s caused
the filing to be made after 9:00 p.m. CST on February 15, 2005, resulting in a February
16, 2005 morning filing date. |
|
|
(2) |
|
Cliff Illig filed a Form 4 on May 9, 2005, reporting the sale of 14,000 shares
of Company Common Stock. This Form 4 included the late filing of 8,000 shares, which
were sold on May 4, 2005. A new broker handling the transaction failed to follow the
communicated reporting protocol, causing a delay in the transaction being reported to
the SEC. The remaining 6,000 shares reported in this Form 4, sold on May 5, 2005, were
timely filed. |
|
|
(3) |
|
Cliff Illig filed a Form 4 on May 20, 2005, which included the late reporting
of the sale of 2,000 shares of Company Common Stock, which shares were sold on May 4,
2005. The new broker reporting the information to the Company for reporting purposes
reported the wrong amount, 8,000 shares, as being sold on May 4, 2005, instead of
10,000 shares. On May 20, 2005, the broker reported that the sale on May
4th was actually 10,000 shares, thus a late Form 4 was filed on May 20, 2005
to include the missing 2,000 shares. |
|
|
(4) |
|
Neal L. Patterson filed a Form 4 on July 29, 2005, which included the late
reporting of the sale of 4,000 shares of Company Common Stock on July 26, 2005. The
late filing was the result of user error in submitting the Form 4 to the SEC. |
19
VOTING SECURITIES AND PRINCIPAL HOLDERS THEREOF
The table below sets forth information, as of March 15, 2006 (unless otherwise indicated below),
with respect to the beneficial ownership of shares of Common Stock by: (a) each person known to us
to own beneficially more than 5% of the aggregate shares of Common Stock outstanding, (b) each
Director and nominee for election as a Director, (c) each executive officer named in the Summary
Compensation Table, and (d) the executive officers and Directors of the Company as a group. Each
of the persons, or group of persons, in the table below has sole voting power and sole dispositive
power as to all of the shares shown as beneficially owned by them, except as otherwise indicated.
|
|
|
|
|
|
|
|
|
|
|
Amount and Nature of |
|
|
Percent of Shares |
|
Name and Address of Beneficial Owner |
|
Beneficial Ownership |
|
|
Outstanding |
|
FMR Corp. |
|
|
8,819,008 |
(1) |
|
|
11.41 |
% |
Waddell & Reed Ivy Investment Company |
|
|
7,519,536 |
(2) |
|
|
9.73 |
% |
Neal L. Patterson |
|
|
7,392,065 |
(3) |
|
|
9.48 |
% |
Wellington Management Company, LLP |
|
|
6,366,630 |
(4) |
|
|
8.24 |
% |
Clifford W. Illig |
|
|
5,202,231 |
(5) |
|
|
6.71 |
% |
Vanguard Specialized Funds-Vanguard Health Care Fund |
|
|
4,959,200 |
(4) |
|
|
6.42 |
% |
Michael E. Herman |
|
|
122,200 |
(6) |
|
|
* |
|
Earl H. Devanny, III |
|
|
120,830 |
|
|
|
* |
|
Jeff Townsend |
|
|
114,549 |
|
|
|
* |
|
Gerald E. Bisbee, Jr., Ph.D. |
|
|
73,200 |
|
|
|
* |
|
John C. Danforth |
|
|
66,840 |
|
|
|
* |
|
William B. Neaves, Ph.D. |
|
|
50,000 |
|
|
|
* |
|
Douglas M. Krebs |
|
|
48,369 |
|
|
|
* |
|
Nancy-Ann DeParle |
|
|
37,100 |
|
|
|
* |
|
Paul M. Black |
|
|
16,944 |
|
|
|
* |
|
William D. Zollars |
|
|
|
|
|
|
n/a |
|
All Directors and executive officers, as a group
(16 persons) |
|
|
13,426,595 |
|
|
|
17.04 |
% |
|
|
|
* |
|
Less than one percent |
|
(1) |
|
According to a Schedule 13G, dated February 14, 2006 and filed by FMR Corp., FMR Corp. has
sole voting power with respect to 779,566 shares of Common Stock and sole dispositive power
with respect to 8,819,008 shares of Common Stock. The address for FMR Corp. is 82 Devonshire
Street, Boston, Massachusetts 02109. |
|
(2) |
|
Schedule 13G, dated February 1, 2006 and filed by Waddell & Reed Financial, Inc. (WDR),
Waddell & Reed Financial Services, Inc. (WRFSI), Waddell & Reed, Inc. (WRI), Waddell &
Reed Investment Management Company (WRIMCO) and Ivy Investment Management Company (IICO),
collectively (Waddell), reported sole voting and dispositive power of the following: |
WDR: 7,519,536 (indirect)
WRFSI: 6,608,036 (indirect)
WRI: 6,608,036 (indirect)
WRIMCO: 6,608,036 (direct)
IICO: 911,500 (direct)
The address for Waddell is 6300 Lamar Avenue, Overland Park, Kansas 66202.
20
(3) |
|
Includes 581,360 shares held in trust for minor children with Jeanne Lillig-Patterson, wife
of Neal L. Patterson, serving as trustee and 108,000 shares for which Mr. Patterson has shared
voting and dispositive power. Excludes 35,682 shares held by Jeanne Lillig-Patterson, wife of
Neal L. Patterson, as to which Mr. Patterson disclaims beneficial ownership. The address for
Mr. Patterson is Cerner Corporation, 2800 Rockcreek Parkway, North Kansas City, Missouri
64117. |
|
(4) |
|
Schedule 13G, dated February 14, 2006 and filed by Wellington Management Company, LLP
(Wellington), reported Wellington having shared voting power with respect to 1,181,210
shares of Common Stock and shared dispositive power with respect to 6,366,630 shares of Common
Stock. The Schedule 13G filed by Wellington also reported that Vanguard Specialized Fund
Vanguard Health Care Fund (Vanguard) owns more than five percent of these shares. Schedule
13G, dated February 13, 2006 and filed by Vanguard reported sole voting power with regard to
4,959,200 shares of common stock. The address for Wellington Management Company, LLP is 75
State Street, Boston, Massachusetts 02109. The address for Vanguard is 100 Vanguard Blvd.,
Malvern, Pennsylvania 19355. |
|
(5) |
|
Includes 391,334 shares held in trust for minor children with Bonne A. Illig, wife of
Clifford W. Illig, serving as trustee and 124,020 shares for which Mr. Illig has shared voting
and dispositive power. The address for Mr. Illig is Cerner Corporation, 2800 Rockcreek
Parkway, North Kansas City, Missouri 64117. |
|
(6) |
|
Excludes 1,600 shares held by Karen Herman, wife of Michael Herman, as to which Mr. Herman
disclaims beneficial ownership. The address for Mr. Herman is Cerner Corporation, 2800
Rockcreek Parkway, North Kansas City, Missouri 64117. |
FINANCIAL STATEMENTS
Our Annual Report to Shareholders for the fiscal year ended December 31, 2005 is enclosed with this
Proxy Statement.
21
PROPOSAL NO. 1
ELECTION OF DIRECTORS
There are two nominees for election to the Board this year. Clifford W. Illig and William B.
Neaves, Ph.D. are Class II Directors and have served on our Board since 1980 and 2001,
respectively. The Board has nominated Messrs. Illig and Neaves for re-election. Unless otherwise
instructed, the persons named as proxies will vote for the election of Messrs. Illig and Neaves.
Each of the Director nominees has agreed to be named in this Proxy Statement and to serve if
elected.
We know of no reason why any of the nominees would not be able to serve. However, if any nominee
is unable or declines to serve as a Director, or if a vacancy occurs before election (which events
are not anticipated), the persons named as proxies will vote for the election of such other person
or persons as are nominated by the Board.
Information concerning each Director nominee is set forth below, along with information about other
members of our Board.
The Companys Board of Directors unanimously recommends
a vote FOR election of the nominees
22
RELATIONSHIP WITH INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Our independent registered public accounting firm during the year ended December 31, 2005 was KPMG.
KPMG has audited our financial statements since 1983.
Audit and Non-Audit Fees
Audit Fees. Fees paid or payable to KPMG totaled $668,000 and $788,000 for professional
services rendered for the audit of our consolidated financial statements for the years ended
December 31, 2005 and January 1, 2005, its reviews of our consolidated financial statements
included in our quarterly reports on Form 10-Q, its audits of foreign subsidiaries in support of
statutory reporting requirements and for its other audit services for the years ended December 31,
2005 and January 1, 2005, respectively.
Audit-Related Fees. KPMG billed us an aggregate of $39,000 and $20,000 for audits of
financial statements of certain employee benefit plans and for routine consultation on accounting
and reporting matters that did not directly affect the consolidated financial statements for the
years ended December 31, 2005 and January 1, 2005, respectively.
Tax Fees. KPMG billed us an aggregate of $240,000 and $120,000 for tax services for the years
ended December 31, 2005 and January 1, 2005, respectively, including fees for services relating to
tax consultation and tax compliance services.
All Other Fees. There were no other fees paid to KPMG for the years ended December 31, 2005
and January 1, 2005.
The Audit Committee has determined that the provision of services by KPMG described in the
preceding paragraphs is compatible with maintaining KPMGs independence. All permissible non-audit
services provided by KPMG in 2005 were pre-approved by the Audit Committee. In addition, no audit
engagement hours were spent by people other than KPMGs full-time, permanent employees.
Pursuant to Section 202 of the Sarbanes-Oxley Act of 2002, our Audit Committee has approved all
auditing and non-audit services performed to date and currently planned to be provided related to
the fiscal year 2006 by our independent registered public accounting firm, KPMG. The services
include the annual audit, quarterly reviews, issuances of consents related to SEC filings and
certain tax compliance services.
PROPOSAL NO. 2
RATIFICATION OF THE APPOINTMENT OF KPMG
AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Our Audit Committee has retained the firm of KPMG LLP as our independent registered public
accounting firm for fiscal year 2006, and we are asking shareholders to ratify that appointment.
In the event the shareholders fail to ratify the appointment, the Audit Committee will reconsider
this appointment but will not necessarily select another firm. Even if the appointment is
ratified, the Audit Committee, in its discretion, may direct the appointment of a different
independent registered public accounting firm at any time during the year if the Audit Committee
determines that such a change would be in the best interests of the Company and our shareholders.
Representatives of KPMG will be present at the Annual Meeting, have the opportunity to make a
statement and be available to answer questions.
The Board of Directors unanimously recommends
a vote FOR the ratification of the appointment of KPMG LLP
as our independent registered public accounting firm for fiscal year 2006
23
PROPOSAL NO. 3
RE-APPROVAL OF THE COMPANYS QUALIFIED PERFORMANCE-BASED COMPENSATION PLAN
FOR THE CORPORATIONS EXECUTIVE OFFICERS FOR PURPOSES OF COMPLYING WITH
SECTION 162(m) OF THE INTERNAL REVENUE CODE
The Board recommends approval of the recently amended Cerner Corporation Performance-based
Compensation Plan (the Performance Plan) for purposes of preserving our ability to fully deduct
the compensation of certain executive officers under Section 162(m) of the Internal Revenue Code.
The Performance Plan was last approved by the Companys shareholders in 2001. The federal tax law
requires certain plans, like the Companys Performance Plan, to be approved or re-approved by
shareholders at least once every five years in order to ensure that all amounts paid under such
plans are fully tax-deductible.
Recent amendments to the Performance Plan, approved by the Compensation Committee on March 6, 2006,
include: (i) additional language to ensure that the Plan meets an exemption under Internal Revenue
Code section 409A (deferred compensation), which additional language commits the Company to
calculating all bonuses as soon as administratively practicable following the end of the quarter or
year for which the bonus is based, and a secondary commitment that all quarterly and annual bonuses
be paid out no later than March 15th of the calendar year following the year in which
such bonus determination is made; (ii) additional language providing that any portion or provision
of the Plan found to contravene in any way with Code section 409A, the regulations thereunder,
regulatory interpretations, etc. would be deemed void and have no effect, and that the Plan shall
be interpreted in a manner so that the Plan complies with Code section 409A; (iii) additional
language providing that executive targets under the Plan based on recognized accounting principles
shall be determined and deemed satisfied by using the same accounting principles in effect and
relied upon when such executive target was established; (iv) the clarification that collection of
cash is an example of a permissible target under the executive function of the Plan; and, (v) an
increase in the maximum amount payable to the Section 16 Insiders of the Company in any calendar
year, increasing the Chief Executive Officers maximum amount payable from 175% to 200% of the
Chief Executive Officers base salary and increasing the other Section 16 Insider officers maximum
amount payable from 150% to 175% of the Section 16 Insider officers base salary, all as set forth
in Annex I.
The Board has determined that it is appropriate and in the best interests of the Company and the
shareholders to ensure that all amounts payable under the Performance Plan are fully tax-deductible
to the Company. The Board has determined, by resolution adopted on March 6, 2006, to submit the
plan to shareholders for their re-approval at this years Annual Meeting. If the shareholders
re-approve the Performance Plan, all amounts paid to associates and executive officers pursuant to
the Performance Plan in forthcoming periods, including at the end of 2006, will be fully
tax-deductible to the Company, generating tax savings.
General Description of the Plan
The following is only a brief summary of the significant provisions of the Performance Plan and is
qualified in its entirety by reference to the full text of the Performance Plan, a copy of which is
attached as Annex I to this Proxy Statement.
The Performance Plan has two components: a general feature and an executive feature. Under the
general feature, a broad range of officers and associates may be eligible to receive awards that
entitle such individuals to quarterly and annual bonus payments if certain pre-determined
performance targets are met for such respective quarters or the year. For the most part,
participants under the general feature of the Performance Plan are sales associates, executives and
those associates which senior management identifies, on an annual basis, as having significant
profit and loss responsibility. The executive feature, which applies only to our executive
officers who are determined by us to be Section 16 Insiders for purposes of Section 16 of the
Securities Exchange Act of 1934, is similar in concept, except that the determination of the
performance targets is less flexible than under the general feature, and the bonus amounts payable
if the targets are met are still subject to additional reductions. The Company expects the total
number of participants in the Performance Plan in 2006 to be approximately 1,200 associates, of
which nine are Section 16 Insiders and participate under the executive feature of the Performance
Plan. Included within the group of individuals eligible to receive awards under the executive
feature of the Performance Plan are all of the named
24
executive officers listed in the Summary Compensation Table of this Proxy Statement.
Purpose
The purpose of the Performance Plan is to provide a meaningful incentive on both a quarterly and
annual basis to our key associates and executive officers and to motivate them to assist us in
achieving ambitious, attainable short-term goals. Individual payments made under the Performance
Plan will vary, depending upon individual performance and, in some cases, business unit operational
achievements. The Performance Plan is administered by the Compensation Committee, which makes all
determinations, including establishment of quarterly and yearly performance targets, the
associates/officers eligible for awards, and the size of individual awards. Administration of the
Executive Feature of the Performance Plan is performed by the Stock Option and Performance-based
Compensation Plan Subcommittee of the Compensation Committee. In making determinations, the
Compensation Committee evaluates managements input and other relevant information.
General Feature
The general feature of the Plan applies to our associates who are not determined to be Section 16
Insiders. The Compensation Committee establishes general performance targets for the year or for
particular quarters, and if such targets are achieved, the Company will pay bonuses to the eligible
participants. The performance targets established by the Compensation Committee may vary from
participant to participant and may include targets based on stock price, earnings per share (with
or without extraordinary items), net income (with or without extraordinary items), return on
equity, return on assets, profit margins on a contract-by-contract basis, collection of certain
accounts receivable, client satisfaction results or achievement of subsidiary business unit
operating plans.
Under the general feature, following the initial determination of performance targets, the
Compensation Committee will monitor actual corporate performance throughout each fiscal quarter,
and may decide at any time before quarter or final year-end determinations are reached to adjust
the earlier target levels as appropriate, for example, to take account of unusual or unanticipated
corporate or industry-wide developments. Final determination of the amounts to be paid to a
participant under the general feature of the plan may also be adjusted upward or downward depending
upon subjective evaluations by an associates executive or manager.
Executive Feature
The executive award feature of the Performance Plan was specifically created and has been
structured so as to ensure that amounts paid to Section 16 Insiders under the Performance Plan are
deductible by the Company for federal income tax purposes.
The principal difference between the general feature of the Performance Plan and the executive
feature is that: (a) separate, more rigid performance targets are set under the executive feature
which cannot be changed during the applicable performance period; and, (b) the maximum amounts
payable to the eligible executive officers if those targets are reached are determined under
pre-established objective formulas.
Tax Law Requiring Shareholder Approval
Section 162(m) of the Internal Revenue Code provides that a publicly-traded company will not be
able to deduct for federal income tax purposes any compensation in excess of $1 million paid by it
in any one year to any covered employee of the company, subject to certain exemptions. Covered
employees are essentially the individuals who were, at the end of the fiscal year, the Companys
chief executive officer and the four other most highly compensated executive officers, i.e., the
officers listed in the Summary Compensation Table in this Proxy Statement. The annual compensation
that is counted under the statute for purposes of the $1 million limit includes, among other
things, base salary and cash bonuses. However, various forms of compensation are exempt from
Section 162(m)s general limitation on deductible compensation, including performance-based
compensation paid under shareholder-approved plans that meet certain criteria. The executive
feature of the Companys Performance Plan meets these criteria. To remain compliant with the
performance-based compensation exemption, such performance-based plans are required to be
re-approved every fifth year by the companys shareholders. Our Performance Plan is up for
re-approval at this years Annual Meeting. Provided shareholder approval is obtained at this
Annual Meeting, any bonuses paid under the plan to covered executives remain tax deductible to
Cerner regardless of the executives total compensation.
25
Operation of the Executive Feature
Under the executive feature of the Performance Plan, no later than the 90th day of each calendar
year (in the case of annual-based awards or a combination of annual and quarterly based awards) or
on or before the twelfth (12th) day of each fiscal quarter (in the case of awards based
solely on performance in such fiscal quarter), the Compensation Committee will set forth in writing
the executive targets for that period of time. The executive targets are drawn from a limited
number of measures specified in the executives individual performance plan agreement. These
targets include: (a) Earnings Per Share, (b) Company Operating Margins, (c) Agreement Margin or (d)
other targets as specifically set forth below and as determined by the Committee.
(a) The Earnings Per Share Target shall be expressed as a specific target earnings per share
for the Companys common stock on a fully diluted basis, before the after-tax effect of any
extraordinary items, the cumulative effect of accounting changes, or other nonrecurring items of
income or expense including restructuring charges.
(b) The Company Operating Margin Target shall be expressed as a target percentage reflecting
the leverage of the Companys revenue relative to the expense associated with that revenue.
(c) The Agreement Margin Targets shall be expressed as a dollar amount of booking margins on
specified types of sales, adjusted for the costs associated with delivery of the solutions.
(d) The Other Targets shall be determined based solely on the following list of targets:
|
(i) |
|
Total shareholder return |
|
|
(ii) |
|
Stock price increase |
|
|
(iii) |
|
Return on equity |
|
|
(iv) |
|
Return on capital |
|
|
(v) |
|
Cash flow, including collection of cash,
operating cash flows, free cash flow, discounted cash flow return on
investment, and cash flow in excess of cost of capital |
|
|
(vi) |
|
Economic value added |
|
|
(vii) |
|
Market share |
|
|
(viii) |
|
Client/associate satisfaction |
|
|
(ix) |
|
Revenue levels |
|
|
(x) |
|
Employee retention |
|
|
(xi) |
|
Productivity measures |
|
|
(xii) |
|
Diversification of business opportunities |
|
|
(xiii) |
|
Price to earnings ratio |
|
|
(xiv) |
|
Expense ratios |
|
|
(xv) |
|
Total expenditures |
|
|
(xvi) |
|
Completion of key projects |
|
|
(xvii) |
|
Operating margin |
The Compensation Committee need not apply all of the above measures to any particular executive for
any year and may select one or more of the measures for any executives and different executives may
have different measures. In selecting one or more measures, the Compensation Committee establishes
a target level of performance for that measure for the forthcoming year or quarters, which may not
be changed after it is selected. Due to the possibility that the specific goals related to a
specific Target may be confidential commercial or business information, and the release of which to
the public may have an adverse affect on the Company, such information has been intentionally
omitted from the Plan and this Proxy Statement as confidential information.
Maximum Payments
The Compensation Committee determines the maximum payment for which the covered executive is
eligible. Such determination is based on a number of factors including but not limited to their
role in the Company, ratio of performance bonus to salary and total potential compensation. The
amount of the bonus payable under the executive feature of the Performance Plan may be reduced but
in no event may the amount of the bonus be increased beyond its
26
maximum limit. The amount of the bonus reduction, if any, will depend upon a
subjective bonus reduction factor, formally known as an Annual Performance Evaluation (APE) Factor,
which will be determined at the covered executives end-of-the-year evaluation. This factor will
range from 100% of the maximum bonus amount for demonstrated distinguished performance to 0% if
performance does not satisfy the required standard. The maximum amount payable to the Chief
Executive Officer under the Plan is 200% of the Chief Executive Officers base salary, and for all
other Section 16 Insiders, 175% of such individuals base salary.
Certification
Prior to making payments under the executive feature of the Performance Plan, the Compensation
Committee must certify in writing that at least one of the preestablished targets for that quarter
or year was satisfied, and the Compensation Committee minutes must reflect this certification.
While the future amounts of the quarterly or annual bonuses that may be paid to executives under
the executive feature of the Performance Plan cannot be determined, the following table indicates
the target and maximum bonus amounts that would have been payable under the Performance Plan in
2005 to each of the named executive officers in the Summary Compensation Table and to all the
current Section 16 Insider officers as a group.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 Maximum Potential |
Name |
|
2005 Target Bonus |
|
Payment |
|
Neal L. Patterson,
Chairman of the Board
and Chief Executive
Officer |
|
$ |
652,500 |
|
|
$ |
1,450,000 |
|
|
Earl H. Devanny, III,
President |
|
$ |
337,500 |
|
|
$ |
735,000 |
|
|
Paul M. Black, Executive
Vice President |
|
$ |
365,000 |
|
|
$ |
682,500 |
|
|
Douglas M. Krebs, Sr.
Vice President |
|
$ |
315,000 |
|
|
$ |
498,750 |
|
|
Jeffrey A. Townsend,
Executive Vice President |
|
$ |
218,750 |
|
|
$ |
568,750 |
|
|
All Section 16 Insider
officers as a group |
|
$ |
2,530,000 |
|
|
$ |
5,755,000 |
|
Approval of the Cerner Corporation Performance-based Compensation Plan
Approval of the proposal to adopt the Cerner Corporation Performance-based Compensation Plan
requires the affirmative vote of the holders of a majority of the shares of Common Stock
represented at the Annual Meeting, in person or by proxy, and entitled to vote thereon.
Abstentions will have the same effect as votes against the proposal. Non-voted shares will not be
considered in attendance for the vote on this proposal.
The Board of Directors unanimously recommends
a vote FOR the re-approval of the qualified Cerner Corporation
Performance-based Compensation Plan
27
SHAREHOLDER PROPOSALS
If a shareholder would like to make a proposal at our 2007 annual meeting, including the nomination
of a director candidate, we must receive written notice no later than the close of business on
December 18, 2006 in order that it may be considered for including in the proxy statement and form
of proxy relating to that meeting. Shareholders wishing to submit proposals or director
nominations that are not to be included in such proxy statement and form of proxy must deliver
notice no later than the close of business on January 25, 2007.
The notice must describe the proposed business, the shareholders name and address, a description
of the class and number of shares of stock of the Company which are beneficially owned (as that
term is defined in our Certificate of Incorporation) by the shareholder, any material interest of
the shareholder in such business and all other information regarding the proposal which the Company
would be required to provide in a proxy statement filed pursuant to the proxy rules of the
Securities and Exchange Commission if proxies for the proposal were being solicited by the Company.
Such proposals must also comply in full with the requirements of Rule 14a-8 under the Securities
Act of 1934 and shareholders are also advised to review our Bylaws, which contain additional
requirements with respect to advance notice of shareholder proposals and Director nominations.
Notice must be sent to our Corporate Secretary at 2800 Rockcreek Parkway, North Kansas City,
Missouri, 64117.
Any notice received after January 25, 2007 is untimely. We reserve the right to reject, rule out
of order, or take other appropriate action with respect to any proposal that does not comply with
these and other applicable requirements. Nominees recommended by shareholders of the Company in
accordance with our advance notice provision will be considered by the Nominating, Governance &
Public Policy Committee for recommendation for nomination by the Board.
OTHER MATTERS
We know of no other matters to be brought before the annual meeting. If any other matter properly
comes before the annual meeting, it is the intention of the persons named in the enclosed proxy
card to vote the shares represented by the proxies as the Board may recommend.
BY ORDER OF THE BOARD OF DIRECTORS,
Randy D. Sims
Secretary
North Kansas City, Missouri
April 17, 2006
28
ANNEX I
CERNER CORPORATION
PERFORMANCE-BASED COMPENSATION PLAN
Amended March 6, 2006
1. |
|
Name. The name of the Plan is the Cerner Corporation Performance Plan (the Plan). |
|
2. |
|
Basic Function. The Plan provides for payment of quarterly and annual bonuses to
select key associates of Cerner Corporation (the Company) and its subsidiaries, depending
upon the financial performance of the Company or certain subsidiaries or business units and/or
the job performance of the individual associates in question. Bonuses, if paid, may be paid
on a quarterly or annual basis and determined based on the actual performance of the Company
or its subsidiaries or business units or on one or more pre-established financial or
operational goals or targets. Payments of awards to certain executives are made pursuant to
the Executive Award Feature (see Section 10). All bonuses will be calculated as soon as
administratively practicable following the end of the quarter or year for which the bonus is
based. All quarterly and annual bonuses will be paid out no later than March 15th
of the calendar year following the year in which such bonus determination is made. |
|
3. |
|
Purpose. The purpose of the Plan is to provide a meaningful incentive on both a
quarterly and annual basis to key associates and officers of the Company and to motivate them
to assist the Company in achieving ambitious and attainable short-term goals. Individual
payments made under the Plan will vary, depending upon individual performance and, in some
cases, business unit operational achievements. |
|
4. |
|
Termination; Amendment. The Plan shall continue to be in effect, unless and until
terminated by the Compensation Committee of the Board of Directors of the Company. The
Executive Award Feature of the Plan is subject to the approval of the shareholders of the
Company, every five (5) years in accordance with Section 162(m) of the Internal Revenue Code,
as amended (the Code) by the affirmative vote of the holders of a majority of the shares
present in person or represented by proxy, and entitled to vote thereon, at a meeting of the
shareholders at which a quorum is present or represented. The Plan may be further amended
from time to time by the Compensation Committee provided that any amendment which, if effected
without the approval of the shareholders of the Company, would result in the loss of an
exemption from federal income tax deduction limitations under Section 162(m) of the Code, for
amounts payable thereunder but would not result in such loss if approved by the shareholders,
shall become effective only upon approval thereof by the shareholders of the Company within
the meaning of Section 162(m). |
|
5. |
|
Administration. The Plan is administered by the Compensation Committee, which has
the sole authority to make all discretionary determinations under the Plan. In suitable
circumstances, the Compensation Committee may evaluate and use the Companys managements
input as well as input and other relevant information from any outside parties it deems
appropriate. |
|
6. |
|
Participation. Key associates and officers eligible for participation in the Plan
will be determined by the Compensation Committee on an annual basis. Executive officers
eligible to receive awards under the Executive Award Feature of the Plan will be identified
each year by the Compensation Committee as described in Section 10 below. |
|
7. |
|
General Feature; Determination of Annual Targets. The Compensation Committee will
determine the measure or measures of financial performance and/or the target levels of
performance, the attainment of which in any quarter or year will result in the payment of
awards to all eligible participants except for those executives covered by the Executive Award
Feature. Such determinations on financial or operational performance measures or target
levels may be made, and under appropriate circumstances may subsequently be modified, by the
Compensation Committee at any time during the calendar year. Alternative performance measures
or targets may be established and different target levels may be selected with different
general bonus amounts established for each participant. Following the initial determination
of performance targets, the Compensation Committee will monitor corporate performance
throughout each fiscal quarter, and may decide at any time before final quarter or year-end
determinations are reached to |
Annex - 1
|
|
adjust the earlier target levels as appropriate, for example, to take into account unusual
or unanticipated corporate or industry-wide developments. Final determinations of the
amounts to be paid to a participant under the general feature of the plan may also be
adjusted upward or downward depending upon subjective evaluations by an associates
executive or manager. |
|
8. |
|
Performance Measures. Measures of financial performance selected by the
Compensation Committee on a quarterly or annual basis for determination of payments of awards
under the general feature of the Plan may include but are not limited to one or more of the
following: stock price, earnings per share (with or without extraordinary items), net income
(with or without extraordinary items), return on equity, return on assets, profit margins on
contract-by-contract basis, collection of certain accounts receivable, client satisfaction
results, or achievement of subsidiary business unit operating plans. Target performance may be
expressed as absolute or average dollar amounts, percentages, changes in dollar amounts or
changes in percentages, and may be considered on an institution-alone basis or measured
against specified peer groups or companies. Notwithstanding the foregoing, the measures of
financial or operational performance for determination of awards payable under the Plan to
those executive officers covered under the Executive Award Feature and the calculation of the
maximum amount payable and amounts actually paid to such executive officers under the Plan
shall be as set forth in the Executive Award Feature of the Plan (see Section 10). |
|
9. |
|
Individual Factors. The Compensation Committee, in exercising discretion under the
Plan on determinations of cash bonuses payable to individuals, may consider particular
individual goals as well as subjective factors, including any unique contributions. |
|
10. |
|
Executive Award Feature. Notwithstanding any other provision of the Plan to the
contrary, any awards granted under the Plan to those individuals identified by the
Compensation Committee as Section 16 insiders of the Company, within the meaning of Security
Exchange Commission Regulations (the Covered Executives), for purposes of this Plan, shall
be governed by the provisions of this Section 10 while such associate is a Covered Executive. |
(i) On or before the ninetieth (90th) day of each calendar year (in the case
of annual-based awards or combination of annual and quarterly based awards), or on or before
the twelfth (12th) day of each fiscal quarter (in the case of awards based solely
on performance in such fiscal quarter) while the Plan is in effect, the Compensation
Committee will (a) identify those individuals who it reasonably believes to be Covered
Executives for such calendar year or fiscal quarter, (b) establish in writing the Earnings
Per Share Target (as defined below) for such calendar year, (c) establish in writing the
Company Operating Margin Target (as defined below) for such quarter or year, (d) establish
in writing the Agreement Margin Targets (as defined below) for such quarter or year, and (e)
establish in writing any other targets for the Covered Executives as specifically set forth
below and as determined by the Compensation Committee and set forth in the Compensation
Committee minutes (Other Targets) (the Earnings Per Share Target, the Company Operating
Margin Target, the Agreement Margin Target, and all Other Targets to be referred to
collectively as the Executive Targets). The Compensation Committee may elect to establish
any combination of the above Executive Targets in a given quarter or year provided that any
established Executive Target(s) be established on or before the end of the ninety day or
twelve day period set forth above. Due to the Compensation Committees belief that the
disclosure of the Executive Targets would adversely affect the Company, the Compensation
Committee, the Covered Executives and all other directors, officers and associates who
become aware of such targets shall and will treat such Executive Targets for any year or
fiscal quarter as confidential. Executive Targets based on recognized accounting principles
shall be determined and deemed satisfied by using the same accounting principles in effect
and relied upon when such Executive Target was established.
(ii) The Earnings Per Share Target shall be expressed as a specific target earnings per
share for the Companys common stock on a fully diluted basis, before the after-tax effect
of any extraordinary items, the cumulative effect of accounting changes, or other
nonrecurring items of income or expense including restructuring charges.
(iii) The Company Operating Margin Target shall be expressed as a target percentage
reflecting the leverage of the Companys revenue relative to the expense associated with
that revenue.
Annex - 2
(iv) The Agreement Margin Targets shall be expressed as a dollar amount of booking
margins on specified types of sales, adjusted for the costs associated with delivery of the
solutions.
(v) The Other Targets shall be determined based solely on the following list of
targets:
|
(a) |
|
Total shareholder return |
|
|
(b) |
|
Stock price increase |
|
|
(c) |
|
Return on equity |
|
|
(d) |
|
Return on capital |
|
|
(e) |
|
Cash flow, including collection of cash,
operating cash flows, free cash flow, discounted cash flow return on
investment, and cash flow in excess of cost of capital |
|
|
(f) |
|
Economic value added |
|
|
(g) |
|
Market share |
|
|
(h) |
|
Client/associate satisfaction |
|
|
(i) |
|
Revenue levels |
|
|
(j) |
|
Employee retention |
|
|
(k) |
|
Productivity measures |
|
|
(l) |
|
Diversification of business opportunities |
|
|
(m) |
|
Price to earnings ratio |
|
|
(n) |
|
Expense ratios |
|
|
(o) |
|
Total expenditures |
|
|
(p) |
|
Completion of key projects |
|
|
(q) |
|
Operating margin |
(vi) If at the end of each fiscal quarter (in the case of quarterly-based performance
targets) or at the end of the fiscal year (in the case of annual-based or combination of
annual and quarterly based performance targets) any of the Executive Targets established by
the Compensation Committee have been met, the maximum amount payable to the Covered
Executives in any calendar year shall be as follows: (a) for the Chief Executive Officer,
200% of the Chief Executive Officers base salary at the time the Executive Targets are
established, and (b) for all other executive officers, 175% of such individuals base salary
at the time the Executive Targets are established. The Compensation Committee has
discretion to reduce the amount of the bonus payable; provided, however, under no
circumstances may the Compensation Committee increase the amount of the bonus payment beyond
its maximum limit. The amount of the bonus reduction, if any, will depend upon a subjective
bonus reduction factor, formally known as an Annual Performance Evaluation (APE) Factor,
which will be determined at the Covered Executives end-of-the-year evaluation. This factor
will range from 100% of the maximum bonus amount for demonstrated distinguished performance
to 0% if performance does not satisfy the required standard.
11. |
|
Certification. Prior to any payment to any Covered Executive of any amount accrued
under Section 10 of this Plan, the Compensation Committee (or its delegated subcommittee)
shall certify in writing that an Executive Target has been satisfied. For purposes of this
certification, approved minutes of the Compensation Committee meeting in which the
certification is made shall satisfy this Plan certification requirement. |
|
12. |
|
Code Section 409A. In the event that any provision of this Plan shall be determined
to contravene Code section 409A, the regulations promulgated thereunder, regulatory
interpretations or announcements with respect to section 409A or applicable judicial decisions
construing section 409A, any such provision shall be void and have no effect. Moreover, this
Plan shall be interpreted at all times in such a manner that the terms and provisions of the
Plan comply with Code section 409A, the regulations promulgated thereunder, regulatory
interpretations or announcements with respect to section 409A and applicable judicial
decisions construing section 409A. |
Annex - 3
TO: Cerner Corporation 401(k) Associate Participants
SUBJECT: Cerner 2006 Annual Meeting of Shareholders: Electronic Voting Instructions
The Annual Meeting of Shareholders of Cerner Corporation (the Company)
will be held at 10:00 a.m., local time, on May 26, 2006. You have
been enrolled to receive shareholder communications and to submit voting
instructions via the Internet.
Please read the following information carefully.
As a participant in the Cerner Corporation Foundations Retirement Plan,
you are entitled to instruct JPMorgan Chase (the Trustee) to vote
the shares of Common Stock of the Company held by you under the Plan
as of March 31, 2006. As of March 31, 2006 your Plan account reflected
123,456,789,012.000000 shares of Common Stock.
The number of shares of Common Stock shown includes any shares of
Common Stock purchased as either an Associate contribution or Company
contribution. Therefore, you may not be vested in the total number
of shares of Common Stock indicated.
There are three items for which you may vote: (i) the election of two
director nominees to serve for a three-year term; (ii) the ratification
of the appointment of KPMG LLP as the independent registered public
accounting firm of the Company for 2006; and, (iii) the re-approval of
the Cerner Corporation Performance-based Compensation Plan.
Details about each of these items are provided in the 2006 Proxy Statement.
The Board of Directors recommends that you vote for these items.
CONTROL NUMBER: 012345678901
You can enter your voting instructions and view the shareholder material at the following
Internet
site. If your browser supports secure transactions you will be automatically directed to a
secure site.
http://www.proxyvote.com/0012345678901
To access ProxyVote, you will need the above CONTROL NUMBER and a four
digit PIN. The PIN number you will need is the last four digits of your
social security number. Internet voting is accepted up to 11:59 p.m.,
EDT, May 25, 2006.
The relevant supporting documentation can also be found at the
following Internet sites:
2005 ANNUAL REPORT
http://www.cerner.com/public/Cerner_2.asp?id=302
2006 PROXY STATEMENT
http://www.cerner.com/public/Cerner_f2.asp?id=301
The Companys 2005 Annual Report and its 2006 Proxy Statement may also
be provided, at the participants request, in hard copy form. To
receive a paper copy of the Companys 2005 Annual Report and its
2006 Proxy Statement, please contact Kelly Askew at (816) 201-5515.
Once you submit your votes the process is complete and your votes will
remain confidential.
VOTE BY INTERNET www.proxyvote.com
Use the Internet to transmit your voting
instructions and for electronic delivery of
information up until 11:59 P.M. EDT on May 25,
2006. Have your proxy card in hand when you access
the web site and follow the instructions to obtain
your records and to create an electronic voting
instruction form.
ELECTRONIC DELIVERY OF FUTURE SHAREHOLDER COMMUNICATIONS
If you would like to reduce the costs incurred by
Cerner Corporation in mailing proxy materials, you
can consent to receiving all future proxy
statements, proxy cards and annual reports
electronically via e-mail or the Internet. To sign
up for electronic delivery, please follow the
instructions above to vote using the Internet and,
when prompted, indicate that you agree to receive
or access shareholder communications electronically
in future years.
VOTE BY PHONE 1-800-690-6903
Use any touch-tone telephone to transmit your
voting instructions up until 11:59 P.M. EDT on May
25, 2006. Have your proxy card in hand when you
call and then follow the instructions.
VOTE BY MAIL
Mark, sign, and date your proxy card and return it
in the postage-paid envelope we have provided or
return it to Cerner Corporation, c/o ADP, 51
Mercedes Way, Edgewood, NY 11717.
IF YOU VOTE OVER THE INTERNET OR BY TELEPHONE,
PLEASE DO NOT MAIL YOUR CARD.
|
|
|
|
|
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: |
|
|
CERNR1
|
|
KEEP THIS PORTION FOR YOUR RECORDS |
|
|
|
|
|
DETACH AND RETURN THIS PORTION ONLY |
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. |
CERNER CORPORATION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
THE BOARD OF DIRECTORS RECOMMENDS
A VOTE FOR PROPOSALS 1, 2 AND 3 |
|
|
|
|
|
|
|
|
|
|
|
|
For |
|
Withhold |
|
For All |
|
To withhold authority to vote for any individual
nominee, mark For All Except and write the nominees name on the line below. |
|
|
|
|
|
|
|
All
|
|
For All
|
|
Except
|
|
|
|
|
1.
|
|
Election of Directors:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
01) Clifford W. Illig |
|
|
|
|
|
|
|
|
|
|
|
|
|
02) William B. Neaves, Ph.D.
|
|
o
|
|
o
|
|
o
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain |
|
|
|
|
|
|
|
|
|
2.
|
|
Ratification of the appointment of KPMG LLP
as the independent registered public accounting
firm of the Company for 2006.
|
|
o
|
|
o
|
|
o |
|
|
|
|
|
|
|
|
|
3.
|
|
Re-approval of the Cerner Corporation
Performance-based Compensation Plan.
|
|
o
|
|
o
|
|
o |
|
|
|
|
|
|
|
|
|
(PLEASE SIGN AND DATE BELOW AND MAIL PROMPTLY IN THE ENCLOSED ENVELOPE)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This proxy, when properly executed, will be voted in the manner directed
herein by the undersigned shareholder(s). If no direction is made, this
proxy will be voted FOR proposals 1, 2 and 3. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In their discretion, the appointed proxies are to vote upon such
other business as may properly come before the meeting which the
Board of Directors does not have knowledge of a reasonable period
of time before the solicitation of this proxy. |
|
|
|
|
|
|
|
|
|
|
|
|
|
Please date and sign as name appears hereon. If shares are
held jointly or by two or more persons, each shareholder
named should sign. Executors, administrators, trustees,
etc. should so indicate when signing. If the signer is a
corporation, please sign full corporate name by duly
authorized officer. If a partnership, please sign in
partnership name by authorized person. |
|
|
|
|
|
|
|
|
|
|
|
Yes
|
|
No |
|
|
|
|
|
|
|
|
|
Please indicate if you plan to attend the 2006 Annual Meeting of Shareholders.
|
|
o
|
|
o
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature [PLEASE SIGN WITHIN BOX]
|
|
Date
|
|
|
|
Signature (Joint Owners)
|
|
Date
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CERNER CORPORATION |
|
|
|
2800 Rockcreek Parkway
|
|
PROXY |
|
North Kansas City, Missouri 64117 |
|
|
|
|
|
|
|
|
|
|
|
|
This Proxy is for the 2006 Annual Meeting of Shareholders of Cerner Corporation, a Delaware
corporation, to be held May 26, 2006, at 10:00 a.m., local time, at The Cerner Round auditorium in
the Cerner Vision Center, located on the Cerner Campus at 2850 Rockcreek Parkway, North Kansas
City, Missouri 64117. |
|
|
|
|
|
THIS PROXY IS SOLICITED BY THE BOARD OF DIRECTORS OF CERNER CORPORATION. |
|
|
|
|
|
The undersigned hereby appoints Clifford W. Illig and Neal L. Patterson, and each of them, jointly
and severally, with full power of substitution, as attorneys-in-fact, to vote all the shares of
Common Stock which the undersigned is entitled to vote at the 2006 Annual Meeting of Shareholders
of Cerner Corporation to be held on May 26, 2006, and at any adjournment thereof, on the
transaction of any and all business which may come before said meeting, as fully and with the same
effect as the undersigned might or could do if personally present for the purposes set forth. |
|
|
|
|
|
The undersigned hereby acknowledges receipt of the Notice of Annual Meeting, Proxy Statement, dated
April 17, 2006, and the 2005 Annual Report to Shareholders. |
|
|
|
|
|
PLEASE MARK, SIGN, DATE AND MAIL THIS PROXY IN THE ENVELOPE PROVIDED.
|
|
|
|
|
|
CONTINUED AND TO BE SIGNED ON REVERSE SIDE
|